Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
NEUROGENESIS |
551 |
1402 |
1.12e-47 |
5.21e-44 |
2 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
609 |
1672 |
1.886e-40 |
4.387e-37 |
3 |
REGULATION OF CELL DIFFERENTIATION |
555 |
1492 |
1.055e-39 |
1.636e-36 |
4 |
CELL DEVELOPMENT |
526 |
1426 |
2.053e-36 |
2.388e-33 |
5 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
332 |
788 |
2.439e-35 |
1.891e-32 |
6 |
CIRCULATORY SYSTEM DEVELOPMENT |
332 |
788 |
2.439e-35 |
1.891e-32 |
7 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
438 |
1142 |
1.068e-34 |
6.214e-32 |
8 |
TISSUE DEVELOPMENT |
547 |
1518 |
1.05e-34 |
6.214e-32 |
9 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
398 |
1021 |
2.822e-33 |
1.459e-30 |
10 |
NEURON DIFFERENTIATION |
353 |
874 |
4.451e-33 |
2.071e-30 |
11 |
REGULATION OF CELL DEVELOPMENT |
338 |
836 |
8.746e-32 |
3.7e-29 |
12 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
373 |
957 |
3.575e-31 |
1.361e-28 |
13 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
234 |
513 |
3.803e-31 |
1.361e-28 |
14 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
462 |
1275 |
7.769e-30 |
2.582e-27 |
15 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
495 |
1395 |
1.727e-29 |
5.358e-27 |
16 |
ORGAN MORPHOGENESIS |
333 |
841 |
2.506e-29 |
7.287e-27 |
17 |
REGULATION OF NEURON DIFFERENTIATION |
243 |
554 |
3.928e-29 |
1.075e-26 |
18 |
VASCULATURE DEVELOPMENT |
215 |
469 |
4.62e-29 |
1.16e-26 |
19 |
CELLULAR COMPONENT MORPHOGENESIS |
350 |
900 |
4.737e-29 |
1.16e-26 |
20 |
REGULATION OF TRANSPORT |
607 |
1804 |
4.999e-29 |
1.163e-26 |
21 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
304 |
750 |
7.379e-29 |
1.635e-26 |
22 |
INTRACELLULAR SIGNAL TRANSDUCTION |
542 |
1572 |
9.689e-29 |
2.049e-26 |
23 |
NEURON PROJECTION DEVELOPMENT |
239 |
545 |
1.192e-28 |
2.411e-26 |
24 |
REGULATION OF CELL PROJECTION ORGANIZATION |
243 |
558 |
1.446e-28 |
2.803e-26 |
25 |
NEURON DEVELOPMENT |
283 |
687 |
2.938e-28 |
5.468e-26 |
26 |
CELL PROJECTION ORGANIZATION |
348 |
902 |
3.924e-28 |
7.022e-26 |
27 |
TUBE DEVELOPMENT |
240 |
552 |
4.229e-28 |
7.288e-26 |
28 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
308 |
771 |
6.138e-28 |
1.02e-25 |
29 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
561 |
1656 |
1.387e-27 |
2.152e-25 |
30 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
598 |
1791 |
1.353e-27 |
2.152e-25 |
31 |
LOCOMOTION |
408 |
1114 |
2.03e-27 |
3.047e-25 |
32 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
321 |
823 |
6.088e-27 |
8.852e-25 |
33 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
188 |
408 |
7.013e-26 |
9.889e-24 |
34 |
NEURON PROJECTION MORPHOGENESIS |
185 |
402 |
2.099e-25 |
2.872e-23 |
35 |
REGULATION OF CELL MORPHOGENESIS |
233 |
552 |
3.869e-25 |
5.144e-23 |
36 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
328 |
872 |
2.423e-24 |
3.132e-22 |
37 |
POSITIVE REGULATION OF CELL COMMUNICATION |
514 |
1532 |
3.634e-24 |
4.569e-22 |
38 |
REGULATION OF CELL PROLIFERATION |
504 |
1496 |
3.903e-24 |
4.779e-22 |
39 |
EPITHELIUM DEVELOPMENT |
348 |
945 |
6.508e-24 |
7.765e-22 |
40 |
BLOOD VESSEL MORPHOGENESIS |
168 |
364 |
2.382e-23 |
2.771e-21 |
41 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
169 |
368 |
3.443e-23 |
3.908e-21 |
42 |
PROTEIN LOCALIZATION |
583 |
1805 |
6.161e-23 |
6.825e-21 |
43 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
158 |
337 |
6.661e-23 |
7.208e-21 |
44 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
577 |
1784 |
7.53e-23 |
7.963e-21 |
45 |
POSITIVE REGULATION OF GENE EXPRESSION |
562 |
1733 |
1.536e-22 |
1.589e-20 |
46 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
268 |
689 |
2.033e-22 |
2.056e-20 |
47 |
TISSUE MORPHOGENESIS |
220 |
533 |
2.645e-22 |
2.619e-20 |
48 |
HEAD DEVELOPMENT |
271 |
709 |
2.184e-21 |
2.117e-19 |
49 |
UROGENITAL SYSTEM DEVELOPMENT |
142 |
299 |
2.289e-21 |
2.174e-19 |
50 |
CELL PART MORPHOGENESIS |
248 |
633 |
2.627e-21 |
2.444e-19 |
51 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
408 |
1192 |
5.782e-21 |
5.276e-19 |
52 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
572 |
1805 |
2.053e-20 |
1.837e-18 |
53 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
495 |
1518 |
2.22e-20 |
1.949e-18 |
54 |
BIOLOGICAL ADHESION |
361 |
1032 |
2.328e-20 |
2.006e-18 |
55 |
NEURON PROJECTION GUIDANCE |
107 |
205 |
2.731e-20 |
2.311e-18 |
56 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
545 |
1710 |
5.001e-20 |
4.155e-18 |
57 |
REGULATION OF CELL DEATH |
481 |
1472 |
5.246e-20 |
4.283e-18 |
58 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
195 |
472 |
5.931e-20 |
4.758e-18 |
59 |
HEART DEVELOPMENT |
193 |
466 |
6.647e-20 |
5.242e-18 |
60 |
TUBE MORPHOGENESIS |
147 |
323 |
6.956e-20 |
5.394e-18 |
61 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
519 |
1618 |
1.054e-19 |
8.036e-18 |
62 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
601 |
1929 |
1.35e-19 |
1.013e-17 |
63 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
183 |
437 |
1.522e-19 |
1.124e-17 |
64 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
350 |
1004 |
1.733e-19 |
1.26e-17 |
65 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
579 |
1848 |
1.868e-19 |
1.337e-17 |
66 |
ANGIOGENESIS |
136 |
293 |
2.031e-19 |
1.432e-17 |
67 |
RESPONSE TO ENDOGENOUS STIMULUS |
472 |
1450 |
2.8e-19 |
1.944e-17 |
68 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
390 |
1152 |
3.872e-19 |
2.649e-17 |
69 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
139 |
306 |
8.721e-19 |
5.881e-17 |
70 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
348 |
1008 |
1.256e-18 |
8.347e-17 |
71 |
MORPHOGENESIS OF AN EPITHELIUM |
169 |
400 |
1.327e-18 |
8.589e-17 |
72 |
EMBRYONIC MORPHOGENESIS |
212 |
539 |
1.329e-18 |
8.589e-17 |
73 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
443 |
1360 |
3.556e-18 |
2.267e-16 |
74 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
136 |
303 |
7.3e-18 |
4.59e-16 |
75 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
111 |
229 |
7.935e-18 |
4.797e-16 |
76 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
605 |
1977 |
7.855e-18 |
4.797e-16 |
77 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
477 |
1492 |
7.938e-18 |
4.797e-16 |
78 |
SKELETAL SYSTEM DEVELOPMENT |
184 |
455 |
9.537e-18 |
5.689e-16 |
79 |
EMBRYO DEVELOPMENT |
312 |
894 |
1.54e-17 |
9.068e-16 |
80 |
ESTABLISHMENT OF LOCALIZATION IN CELL |
524 |
1676 |
2.071e-17 |
1.205e-15 |
81 |
RESPONSE TO GROWTH FACTOR |
189 |
475 |
2.52e-17 |
1.448e-15 |
82 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
111 |
232 |
2.673e-17 |
1.517e-15 |
83 |
PROTEIN PHOSPHORYLATION |
325 |
944 |
2.98e-17 |
1.671e-15 |
84 |
REGULATION OF AXONOGENESIS |
88 |
168 |
4.576e-17 |
2.535e-15 |
85 |
REGULATION OF GTPASE ACTIVITY |
247 |
673 |
5.04e-17 |
2.759e-15 |
86 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
238 |
643 |
6.049e-17 |
3.273e-15 |
87 |
CELL MOTILITY |
293 |
835 |
6.878e-17 |
3.637e-15 |
88 |
LOCALIZATION OF CELL |
293 |
835 |
6.878e-17 |
3.637e-15 |
89 |
REGULATION OF CELLULAR LOCALIZATION |
415 |
1277 |
7.143e-17 |
3.735e-15 |
90 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
312 |
905 |
1.082e-16 |
5.594e-15 |
91 |
REGULATION OF PROTEIN LOCALIZATION |
324 |
950 |
1.534e-16 |
7.841e-15 |
92 |
GLAND DEVELOPMENT |
162 |
395 |
1.922e-16 |
9.721e-15 |
93 |
NEGATIVE REGULATION OF CELL DEATH |
301 |
872 |
3.207e-16 |
1.604e-14 |
94 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
373 |
1135 |
4.685e-16 |
2.319e-14 |
95 |
ESTABLISHMENT OF PROTEIN LOCALIZATION |
450 |
1423 |
6.212e-16 |
3.043e-14 |
96 |
REGULATION OF DEVELOPMENTAL GROWTH |
126 |
289 |
1.866e-15 |
9.042e-14 |
97 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
124 |
285 |
3.763e-15 |
1.805e-13 |
98 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
189 |
498 |
6.526e-15 |
3.098e-13 |
99 |
FOREBRAIN DEVELOPMENT |
146 |
357 |
7.859e-15 |
3.694e-13 |
100 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
221 |
609 |
9.502e-15 |
4.421e-13 |
101 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
266 |
767 |
9.874e-15 |
4.549e-13 |
102 |
POSITIVE REGULATION OF TRANSPORT |
313 |
936 |
1.02e-14 |
4.653e-13 |
103 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
275 |
801 |
1.383e-14 |
6.249e-13 |
104 |
POSITIVE REGULATION OF LOCOMOTION |
164 |
420 |
2.357e-14 |
1.054e-12 |
105 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
81 |
162 |
2.436e-14 |
1.079e-12 |
106 |
DIGESTIVE SYSTEM DEVELOPMENT |
76 |
148 |
2.481e-14 |
1.089e-12 |
107 |
EXTRACELLULAR STRUCTURE ORGANIZATION |
128 |
304 |
2.758e-14 |
1.199e-12 |
108 |
REGULATION OF HYDROLASE ACTIVITY |
416 |
1327 |
3.974e-14 |
1.712e-12 |
109 |
TELENCEPHALON DEVELOPMENT |
103 |
228 |
4.298e-14 |
1.835e-12 |
110 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
430 |
1381 |
4.593e-14 |
1.943e-12 |
111 |
REGULATION OF GROWTH |
225 |
633 |
6.786e-14 |
2.844e-12 |
112 |
CELLULAR MACROMOLECULE LOCALIZATION |
389 |
1234 |
1.198e-13 |
4.975e-12 |
113 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
292 |
876 |
1.308e-13 |
5.386e-12 |
114 |
STEM CELL DIFFERENTIATION |
89 |
190 |
1.755e-13 |
7.165e-12 |
115 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
335 |
1036 |
1.857e-13 |
7.449e-12 |
116 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
335 |
1036 |
1.857e-13 |
7.449e-12 |
117 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
81 |
167 |
2.043e-13 |
8.125e-12 |
118 |
POSITIVE REGULATION OF CELL PROLIFERATION |
274 |
814 |
2.17e-13 |
8.557e-12 |
119 |
CONNECTIVE TISSUE DEVELOPMENT |
90 |
194 |
2.59e-13 |
1.013e-11 |
120 |
PHOSPHORYLATION |
385 |
1228 |
3.839e-13 |
1.489e-11 |
121 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
319 |
983 |
4.418e-13 |
1.699e-11 |
122 |
APPENDAGE DEVELOPMENT |
81 |
169 |
4.597e-13 |
1.739e-11 |
123 |
LIMB DEVELOPMENT |
81 |
169 |
4.597e-13 |
1.739e-11 |
124 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
268 |
799 |
6.319e-13 |
2.371e-11 |
125 |
REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
116 |
278 |
9.203e-13 |
3.426e-11 |
126 |
RESPONSE TO WOUNDING |
201 |
563 |
9.415e-13 |
3.477e-11 |
127 |
TAXIS |
172 |
464 |
1.165e-12 |
4.243e-11 |
128 |
MESENCHYMAL CELL DIFFERENTIATION |
68 |
134 |
1.167e-12 |
4.243e-11 |
129 |
REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY |
101 |
232 |
1.265e-12 |
4.563e-11 |
130 |
REGULATION OF OSSIFICATION |
83 |
178 |
1.543e-12 |
5.522e-11 |
131 |
MESENCHYME DEVELOPMENT |
87 |
190 |
1.587e-12 |
5.636e-11 |
132 |
SENSORY ORGAN DEVELOPMENT |
180 |
493 |
1.622e-12 |
5.718e-11 |
133 |
HEART MORPHOGENESIS |
94 |
212 |
2.092e-12 |
7.317e-11 |
134 |
CELL CELL ADHESION |
212 |
608 |
3.057e-12 |
1.061e-10 |
135 |
HOMEOSTATIC PROCESS |
409 |
1337 |
3.466e-12 |
1.195e-10 |
136 |
MUSCLE STRUCTURE DEVELOPMENT |
161 |
432 |
3.739e-12 |
1.279e-10 |
137 |
MEMBRANE ORGANIZATION |
292 |
899 |
4.078e-12 |
1.385e-10 |
138 |
EPITHELIAL CELL DIFFERENTIATION |
179 |
495 |
4.85e-12 |
1.635e-10 |
139 |
CELL DEATH |
319 |
1001 |
5.366e-12 |
1.796e-10 |
140 |
CELL PROLIFERATION |
229 |
672 |
5.588e-12 |
1.857e-10 |
141 |
RESPONSE TO ABIOTIC STIMULUS |
325 |
1024 |
5.834e-12 |
1.925e-10 |
142 |
POSITIVE REGULATION OF CELL DEATH |
210 |
605 |
6.297e-12 |
2.064e-10 |
143 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
169 |
462 |
6.534e-12 |
2.126e-10 |
144 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
91 |
207 |
8.391e-12 |
2.711e-10 |
145 |
REGULATION OF ORGAN MORPHOGENESIS |
102 |
242 |
1.048e-11 |
3.364e-10 |
146 |
KIDNEY EPITHELIUM DEVELOPMENT |
63 |
125 |
1.145e-11 |
3.65e-10 |
147 |
DIGESTIVE TRACT MORPHOGENESIS |
33 |
48 |
1.408e-11 |
4.456e-10 |
148 |
OSSIFICATION |
104 |
251 |
2.261e-11 |
7.109e-10 |
149 |
VESICLE MEDIATED TRANSPORT |
379 |
1239 |
2.339e-11 |
7.303e-10 |
150 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
53 |
99 |
2.522e-11 |
7.771e-10 |
151 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
53 |
99 |
2.522e-11 |
7.771e-10 |
152 |
REGULATION OF ION TRANSPORT |
204 |
592 |
2.671e-11 |
8.176e-10 |
153 |
REGULATION OF CELL ADHESION |
214 |
629 |
3.323e-11 |
1.011e-09 |
154 |
REGULATION OF CELL SIZE |
78 |
172 |
4.003e-11 |
1.209e-09 |
155 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
64 |
131 |
4.478e-11 |
1.344e-09 |
156 |
REGULATION OF KINASE ACTIVITY |
254 |
776 |
4.521e-11 |
1.349e-09 |
157 |
POSITIVE REGULATION OF AXONOGENESIS |
41 |
69 |
5.682e-11 |
1.684e-09 |
158 |
DEVELOPMENTAL GROWTH |
128 |
333 |
5.724e-11 |
1.686e-09 |
159 |
PEPTIDYL AMINO ACID MODIFICATION |
271 |
841 |
6.389e-11 |
1.87e-09 |
160 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
57 |
112 |
6.571e-11 |
1.911e-09 |
161 |
REGULATION OF EXTENT OF CELL GROWTH |
53 |
101 |
6.866e-11 |
1.984e-09 |
162 |
MUSCLE TISSUE DEVELOPMENT |
110 |
275 |
8e-11 |
2.298e-09 |
163 |
REGULATION OF HOMEOSTATIC PROCESS |
161 |
447 |
8.156e-11 |
2.328e-09 |
164 |
SECRETION |
201 |
588 |
8.333e-11 |
2.364e-09 |
165 |
CHEMICAL HOMEOSTASIS |
279 |
874 |
1.01e-10 |
2.847e-09 |
166 |
SINGLE ORGANISM CELL ADHESION |
164 |
459 |
1.107e-10 |
3.103e-09 |
167 |
GLIOGENESIS |
78 |
175 |
1.127e-10 |
3.14e-09 |
168 |
EYE DEVELOPMENT |
125 |
326 |
1.156e-10 |
3.202e-09 |
169 |
CELLULAR RESPONSE TO NITROGEN COMPOUND |
177 |
505 |
1.21e-10 |
3.331e-09 |
170 |
REGULATION OF MEMBRANE POTENTIAL |
130 |
343 |
1.222e-10 |
3.344e-09 |
171 |
ION TRANSPORT |
381 |
1262 |
1.329e-10 |
3.617e-09 |
172 |
RESPONSE TO OXYGEN LEVELS |
120 |
311 |
1.71e-10 |
4.626e-09 |
173 |
IMMUNE SYSTEM DEVELOPMENT |
198 |
582 |
1.833e-10 |
4.93e-09 |
174 |
POSITIVE REGULATION OF OSSIFICATION |
46 |
84 |
1.866e-10 |
4.991e-09 |
175 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
67 |
144 |
2.382e-10 |
6.334e-09 |
176 |
REGULATION OF MAPK CASCADE |
219 |
660 |
2.61e-10 |
6.901e-09 |
177 |
REGULATION OF CELLULAR PROTEIN LOCALIZATION |
189 |
552 |
2.636e-10 |
6.929e-09 |
178 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
117 |
303 |
2.732e-10 |
7.142e-09 |
179 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
59 |
121 |
2.793e-10 |
7.261e-09 |
180 |
REGULATION OF TRANSFERASE ACTIVITY |
296 |
946 |
3.03e-10 |
7.834e-09 |
181 |
RESPIRATORY SYSTEM DEVELOPMENT |
84 |
197 |
3.406e-10 |
8.755e-09 |
182 |
GROWTH |
148 |
410 |
3.938e-10 |
1.007e-08 |
183 |
RESPONSE TO NITROGEN COMPOUND |
272 |
859 |
4.386e-10 |
1.115e-08 |
184 |
CEREBRAL CORTEX DEVELOPMENT |
53 |
105 |
4.486e-10 |
1.134e-08 |
185 |
CELL SUBSTRATE ADHESION |
73 |
164 |
4.735e-10 |
1.191e-08 |
186 |
GLAND MORPHOGENESIS |
50 |
97 |
5.376e-10 |
1.345e-08 |
187 |
CARBOHYDRATE DERIVATIVE METABOLIC PROCESS |
321 |
1047 |
6.644e-10 |
1.653e-08 |
188 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
239 |
740 |
7.009e-10 |
1.735e-08 |
189 |
CARDIAC CHAMBER DEVELOPMENT |
66 |
144 |
7.125e-10 |
1.745e-08 |
190 |
CARTILAGE DEVELOPMENT |
67 |
147 |
7.121e-10 |
1.745e-08 |
191 |
BEHAVIOR |
177 |
516 |
8.304e-10 |
2.023e-08 |
192 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
286 |
917 |
8.863e-10 |
2.148e-08 |
193 |
RESPONSE TO EXTERNAL STIMULUS |
519 |
1821 |
9.311e-10 |
2.244e-08 |
194 |
REGULATION OF CATABOLIC PROCESS |
236 |
731 |
9.357e-10 |
2.244e-08 |
195 |
GLIAL CELL DIFFERENTIATION |
63 |
136 |
1.012e-09 |
2.414e-08 |
196 |
CELL JUNCTION ORGANIZATION |
79 |
185 |
1.039e-09 |
2.466e-08 |
197 |
REGULATION OF TRANSMEMBRANE TRANSPORT |
151 |
426 |
1.145e-09 |
2.705e-08 |
198 |
REGULATION OF ANATOMICAL STRUCTURE SIZE |
164 |
472 |
1.205e-09 |
2.817e-08 |
199 |
REGULATION OF CELL SUBSTRATE ADHESION |
75 |
173 |
1.2e-09 |
2.817e-08 |
200 |
REGULATION OF CELLULAR COMPONENT SIZE |
125 |
337 |
1.334e-09 |
3.105e-08 |
201 |
CELLULAR RESPONSE TO EXTERNAL STIMULUS |
103 |
264 |
1.622e-09 |
3.755e-08 |
202 |
REGULATION OF BODY FLUID LEVELS |
173 |
506 |
1.705e-09 |
3.926e-08 |
203 |
PATTERN SPECIFICATION PROCESS |
148 |
418 |
1.823e-09 |
4.178e-08 |
204 |
REGULATION OF METAL ION TRANSPORT |
121 |
325 |
1.88e-09 |
4.288e-08 |
205 |
POSITIVE REGULATION OF DEVELOPMENTAL GROWTH |
69 |
156 |
1.951e-09 |
4.428e-08 |
206 |
SECRETION BY CELL |
167 |
486 |
2.154e-09 |
4.866e-08 |
207 |
ENDOMEMBRANE SYSTEM ORGANIZATION |
161 |
465 |
2.272e-09 |
5.107e-08 |
208 |
REGULATION OF WNT SIGNALING PATHWAY |
116 |
310 |
2.873e-09 |
6.427e-08 |
209 |
POSITIVE REGULATION OF MAPK CASCADE |
162 |
470 |
2.921e-09 |
6.503e-08 |
210 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
221 |
684 |
2.992e-09 |
6.63e-08 |
211 |
POSITIVE REGULATION OF KINASE ACTIVITY |
165 |
482 |
3.657e-09 |
8.065e-08 |
212 |
MESONEPHROS DEVELOPMENT |
46 |
90 |
3.72e-09 |
8.166e-08 |
213 |
REGULATION OF SYNAPSE ORGANIZATION |
54 |
113 |
3.925e-09 |
8.574e-08 |
214 |
REGULATION OF CELL GROWTH |
139 |
391 |
4.191e-09 |
9.112e-08 |
215 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
63 |
140 |
4.235e-09 |
9.165e-08 |
216 |
REGULATION OF ACTIN FILAMENT BASED PROCESS |
116 |
312 |
4.424e-09 |
9.529e-08 |
217 |
RESPONSE TO HORMONE |
276 |
893 |
4.709e-09 |
1.01e-07 |
218 |
CARDIAC SEPTUM DEVELOPMENT |
44 |
85 |
4.853e-09 |
1.036e-07 |
219 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
50 |
102 |
4.983e-09 |
1.059e-07 |
220 |
REGULATION OF SECRETION |
224 |
699 |
5.133e-09 |
1.086e-07 |
221 |
RESPONSE TO MECHANICAL STIMULUS |
85 |
210 |
5.613e-09 |
1.182e-07 |
222 |
CELL JUNCTION ASSEMBLY |
59 |
129 |
6.166e-09 |
1.292e-07 |
223 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
147 |
422 |
7.146e-09 |
1.491e-07 |
224 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
230 |
724 |
7.394e-09 |
1.536e-07 |
225 |
REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
84 |
208 |
7.805e-09 |
1.614e-07 |
226 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
130 |
363 |
7.913e-09 |
1.629e-07 |
227 |
PEPTIDYL SERINE MODIFICATION |
65 |
148 |
7.999e-09 |
1.64e-07 |
228 |
NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
151 |
437 |
8.288e-09 |
1.691e-07 |
229 |
INTRACELLULAR PROTEIN TRANSPORT |
245 |
781 |
8.39e-09 |
1.705e-07 |
230 |
COGNITION |
97 |
251 |
8.491e-09 |
1.718e-07 |
231 |
NEPHRON DEVELOPMENT |
54 |
115 |
8.556e-09 |
1.718e-07 |
232 |
GLYCOPROTEIN METABOLIC PROCESS |
127 |
353 |
8.565e-09 |
1.718e-07 |
233 |
IMMUNE SYSTEM PROCESS |
553 |
1984 |
8.951e-09 |
1.788e-07 |
234 |
WOUND HEALING |
160 |
470 |
9.721e-09 |
1.933e-07 |
235 |
REGULATION OF CYTOPLASMIC TRANSPORT |
163 |
481 |
1.014e-08 |
2.007e-07 |
236 |
EMBRYONIC ORGAN MORPHOGENESIS |
105 |
279 |
1.118e-08 |
2.2e-07 |
237 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
78 |
190 |
1.121e-08 |
2.2e-07 |
238 |
NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
179 |
541 |
1.436e-08 |
2.796e-07 |
239 |
NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
179 |
541 |
1.436e-08 |
2.796e-07 |
240 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
66 |
153 |
1.472e-08 |
2.841e-07 |
241 |
PALLIUM DEVELOPMENT |
66 |
153 |
1.472e-08 |
2.841e-07 |
242 |
REGULATION OF CARTILAGE DEVELOPMENT |
35 |
63 |
1.664e-08 |
3.199e-07 |
243 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
61 |
138 |
1.698e-08 |
3.238e-07 |
244 |
ODONTOGENESIS |
50 |
105 |
1.692e-08 |
3.238e-07 |
245 |
EMBRYONIC ORGAN DEVELOPMENT |
141 |
406 |
1.79e-08 |
3.399e-07 |
246 |
MAMMARY GLAND DEVELOPMENT |
54 |
117 |
1.809e-08 |
3.423e-07 |
247 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
199 |
616 |
1.861e-08 |
3.507e-07 |
248 |
PROTEIN AUTOPHOSPHORYLATION |
78 |
192 |
1.938e-08 |
3.635e-07 |
249 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
36 |
66 |
1.999e-08 |
3.715e-07 |
250 |
POSITIVE REGULATION OF GROWTH |
92 |
238 |
2.004e-08 |
3.715e-07 |
251 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
36 |
66 |
1.999e-08 |
3.715e-07 |
252 |
REGULATION OF SYSTEM PROCESS |
169 |
507 |
2.033e-08 |
3.755e-07 |
253 |
SINGLE ORGANISM CELLULAR LOCALIZATION |
274 |
898 |
2.046e-08 |
3.763e-07 |
254 |
SYNAPSE ORGANIZATION |
63 |
145 |
2.229e-08 |
4.083e-07 |
255 |
NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
99 |
262 |
2.293e-08 |
4.183e-07 |
256 |
RESPONSE TO ALCOHOL |
128 |
362 |
2.447e-08 |
4.447e-07 |
257 |
CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND |
157 |
465 |
2.488e-08 |
4.505e-07 |
258 |
INOSITOL LIPID MEDIATED SIGNALING |
56 |
124 |
2.579e-08 |
4.652e-07 |
259 |
PLASMA MEMBRANE ORGANIZATION |
81 |
203 |
2.709e-08 |
4.867e-07 |
260 |
OUTFLOW TRACT MORPHOGENESIS |
32 |
56 |
2.724e-08 |
4.874e-07 |
261 |
METAL ION TRANSPORT |
189 |
582 |
2.758e-08 |
4.879e-07 |
262 |
REGULATION OF RESPONSE TO STRESS |
420 |
1468 |
2.738e-08 |
4.879e-07 |
263 |
REGULATION OF ORGANELLE ORGANIZATION |
346 |
1178 |
2.754e-08 |
4.879e-07 |
264 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
158 |
470 |
3.115e-08 |
5.49e-07 |
265 |
MODULATION OF SYNAPTIC TRANSMISSION |
110 |
301 |
3.219e-08 |
5.652e-07 |
266 |
HINDBRAIN DEVELOPMENT |
60 |
137 |
3.356e-08 |
5.87e-07 |
267 |
POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
170 |
514 |
3.405e-08 |
5.933e-07 |
268 |
CELL FATE COMMITMENT |
88 |
227 |
3.452e-08 |
5.993e-07 |
269 |
MUSCLE CELL DIFFERENTIATION |
91 |
237 |
3.469e-08 |
6.001e-07 |
270 |
METANEPHROS DEVELOPMENT |
41 |
81 |
3.701e-08 |
6.362e-07 |
271 |
REGULATION OF INTRACELLULAR TRANSPORT |
199 |
621 |
3.705e-08 |
6.362e-07 |
272 |
CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT |
53 |
116 |
3.732e-08 |
6.384e-07 |
273 |
SKELETAL SYSTEM MORPHOGENESIS |
80 |
201 |
3.75e-08 |
6.392e-07 |
274 |
VENTRICULAR SEPTUM DEVELOPMENT |
31 |
54 |
3.868e-08 |
6.568e-07 |
275 |
ACTIN FILAMENT BASED PROCESS |
152 |
450 |
4.012e-08 |
6.788e-07 |
276 |
WNT SIGNALING PATHWAY |
124 |
351 |
4.266e-08 |
7.173e-07 |
277 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
69 |
166 |
4.27e-08 |
7.173e-07 |
278 |
REGULATION OF CELL MATRIX ADHESION |
44 |
90 |
4.518e-08 |
7.561e-07 |
279 |
ION TRANSMEMBRANE TRANSPORT |
252 |
822 |
4.899e-08 |
8.171e-07 |
280 |
SINGLE ORGANISM BEHAVIOR |
133 |
384 |
5.399e-08 |
8.972e-07 |
281 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
180 |
554 |
5.655e-08 |
9.337e-07 |
282 |
RESPONSE TO LIPID |
269 |
888 |
5.659e-08 |
9.337e-07 |
283 |
NEGATIVE REGULATION OF GENE EXPRESSION |
424 |
1493 |
6.036e-08 |
9.897e-07 |
284 |
CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS |
191 |
595 |
6.041e-08 |
9.897e-07 |
285 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
430 |
1517 |
6.143e-08 |
1.003e-06 |
286 |
REGULATION OF VASCULATURE DEVELOPMENT |
89 |
233 |
6.462e-08 |
1.051e-06 |
287 |
ENSHEATHMENT OF NEURONS |
44 |
91 |
6.831e-08 |
1.104e-06 |
288 |
AXON ENSHEATHMENT |
44 |
91 |
6.831e-08 |
1.104e-06 |
289 |
CARDIAC VENTRICLE DEVELOPMENT |
49 |
106 |
7.646e-08 |
1.231e-06 |
290 |
CELLULAR RESPONSE TO OXYGEN LEVELS |
61 |
143 |
8.339e-08 |
1.338e-06 |
291 |
CELL ACTIVATION |
183 |
568 |
8.565e-08 |
1.37e-06 |
292 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
216 |
691 |
8.776e-08 |
1.394e-06 |
293 |
CELLULAR HOMEOSTASIS |
212 |
676 |
8.771e-08 |
1.394e-06 |
294 |
NEURAL CREST CELL DIFFERENTIATION |
38 |
75 |
1.119e-07 |
1.771e-06 |
295 |
EPITHELIAL CELL DEVELOPMENT |
74 |
186 |
1.219e-07 |
1.923e-06 |
296 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
64 |
154 |
1.309e-07 |
2.057e-06 |
297 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
138 |
408 |
1.526e-07 |
2.391e-06 |
298 |
PEPTIDYL THREONINE MODIFICATION |
27 |
46 |
1.552e-07 |
2.406e-06 |
299 |
REGULATION OF CHONDROCYTE DIFFERENTIATION |
27 |
46 |
1.552e-07 |
2.406e-06 |
300 |
CARDIOCYTE DIFFERENTIATION |
45 |
96 |
1.546e-07 |
2.406e-06 |
301 |
NEGATIVE REGULATION OF NEURON DIFFERENTIATION |
75 |
191 |
1.882e-07 |
2.909e-06 |
302 |
REGULATION OF ION HOMEOSTASIS |
78 |
201 |
1.924e-07 |
2.964e-06 |
303 |
KIDNEY MORPHOGENESIS |
40 |
82 |
1.97e-07 |
3.025e-06 |
304 |
PALATE DEVELOPMENT |
41 |
85 |
2.057e-07 |
3.148e-06 |
305 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
51 |
115 |
2.161e-07 |
3.296e-06 |
306 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
32 |
60 |
2.431e-07 |
3.697e-06 |
307 |
REGULATION OF CYTOSKELETON ORGANIZATION |
163 |
502 |
2.484e-07 |
3.765e-06 |
308 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
88 |
236 |
2.677e-07 |
4.044e-06 |
309 |
AMINO ACID IMPORT |
13 |
15 |
2.769e-07 |
4.17e-06 |
310 |
CATION TRANSPORT |
241 |
796 |
2.943e-07 |
4.418e-06 |
311 |
TRANSMEMBRANE TRANSPORT |
319 |
1098 |
3.075e-07 |
4.601e-06 |
312 |
CELLULAR RESPONSE TO STRESS |
437 |
1565 |
3.127e-07 |
4.664e-06 |
313 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
44 |
95 |
3.24e-07 |
4.816e-06 |
314 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
136 |
406 |
3.498e-07 |
5.184e-06 |
315 |
REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION |
72 |
184 |
3.838e-07 |
5.669e-06 |
316 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
123 |
360 |
3.879e-07 |
5.711e-06 |
317 |
ARTERY DEVELOPMENT |
37 |
75 |
3.907e-07 |
5.735e-06 |
318 |
INTERSPECIES INTERACTION BETWEEN ORGANISMS |
205 |
662 |
3.979e-07 |
5.803e-06 |
319 |
SYMBIOSIS ENCOMPASSING MUTUALISM THROUGH PARASITISM |
205 |
662 |
3.979e-07 |
5.803e-06 |
320 |
REGULATION OF DENDRITE DEVELOPMENT |
52 |
120 |
4.036e-07 |
5.869e-06 |
321 |
ION HOMEOSTASIS |
182 |
576 |
4.097e-07 |
5.938e-06 |
322 |
RENAL TUBULE DEVELOPMENT |
38 |
78 |
4.117e-07 |
5.949e-06 |
323 |
REGULATION OF BINDING |
101 |
283 |
4.28e-07 |
6.165e-06 |
324 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
29 |
53 |
4.319e-07 |
6.202e-06 |
325 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION |
49 |
111 |
4.393e-07 |
6.29e-06 |
326 |
DIVALENT INORGANIC CATION HOMEOSTASIS |
118 |
343 |
4.44e-07 |
6.338e-06 |
327 |
NEPHRON EPITHELIUM DEVELOPMENT |
43 |
93 |
4.658e-07 |
6.628e-06 |
328 |
NEGATIVE REGULATION OF LOCOMOTION |
95 |
263 |
5.003e-07 |
7.098e-06 |
329 |
POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT |
30 |
56 |
5.063e-07 |
7.139e-06 |
330 |
SENSORY ORGAN MORPHOGENESIS |
88 |
239 |
5.061e-07 |
7.139e-06 |
331 |
GOLGI VESICLE TRANSPORT |
111 |
319 |
5.095e-07 |
7.162e-06 |
332 |
RHYTHMIC PROCESS |
105 |
298 |
5.192e-07 |
7.276e-06 |
333 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
175 |
552 |
5.359e-07 |
7.488e-06 |
334 |
BONE DEVELOPMENT |
63 |
156 |
5.525e-07 |
7.697e-06 |
335 |
REGULATION OF SYNAPTIC PLASTICITY |
58 |
140 |
5.635e-07 |
7.826e-06 |
336 |
COLLAGEN FIBRIL ORGANIZATION |
23 |
38 |
6.024e-07 |
8.317e-06 |
337 |
SUBSTRATE ADHESION DEPENDENT CELL SPREADING |
23 |
38 |
6.024e-07 |
8.317e-06 |
338 |
REGULATION OF SYNAPSE ASSEMBLY |
38 |
79 |
6.202e-07 |
8.538e-06 |
339 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
46 |
103 |
6.525e-07 |
8.956e-06 |
340 |
REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
45 |
100 |
6.619e-07 |
9.058e-06 |
341 |
ACTION POTENTIAL |
43 |
94 |
6.709e-07 |
9.154e-06 |
342 |
DIVALENT INORGANIC CATION TRANSPORT |
96 |
268 |
6.754e-07 |
9.19e-06 |
343 |
REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
82 |
220 |
6.861e-07 |
9.308e-06 |
344 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
52 |
122 |
7.518e-07 |
1.017e-05 |
345 |
NERVE DEVELOPMENT |
34 |
68 |
7.682e-07 |
1.036e-05 |
346 |
CELL MATRIX ADHESION |
51 |
119 |
7.826e-07 |
1.049e-05 |
347 |
L AMINO ACID IMPORT |
11 |
12 |
7.823e-07 |
1.049e-05 |
348 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
75 |
197 |
7.861e-07 |
1.051e-05 |
349 |
CELLULAR CHEMICAL HOMEOSTASIS |
179 |
570 |
7.96e-07 |
1.061e-05 |
350 |
POSITIVE REGULATION OF AXON EXTENSION |
22 |
36 |
8.389e-07 |
1.115e-05 |
351 |
REGULATION OF STEM CELL DIFFERENTIATION |
49 |
113 |
8.409e-07 |
1.115e-05 |
352 |
PROTEIN LOCALIZATION TO MEMBRANE |
126 |
376 |
9.086e-07 |
1.201e-05 |
353 |
CARDIAC CHAMBER MORPHOGENESIS |
46 |
104 |
9.14e-07 |
1.201e-05 |
354 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
46 |
104 |
9.14e-07 |
1.201e-05 |
355 |
CELLULAR RESPONSE TO MECHANICAL STIMULUS |
38 |
80 |
9.237e-07 |
1.211e-05 |
356 |
MEMORY |
44 |
98 |
9.473e-07 |
1.235e-05 |
357 |
REGULATION OF MAP KINASE ACTIVITY |
110 |
319 |
9.454e-07 |
1.235e-05 |
358 |
RESPONSE TO STEROID HORMONE |
159 |
497 |
9.573e-07 |
1.244e-05 |
359 |
CELLULAR RESPONSE TO ABIOTIC STIMULUS |
94 |
263 |
9.826e-07 |
1.274e-05 |
360 |
REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
19 |
29 |
1.025e-06 |
1.325e-05 |
361 |
CELLULAR RESPONSE TO LIPID |
148 |
457 |
1.036e-06 |
1.335e-05 |
362 |
MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL |
12 |
14 |
1.062e-06 |
1.365e-05 |
363 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
50 |
117 |
1.108e-06 |
1.42e-05 |
364 |
LEUKOCYTE DIFFERENTIATION |
102 |
292 |
1.184e-06 |
1.513e-05 |
365 |
REGULATION OF PROTEIN CATABOLIC PROCESS |
130 |
393 |
1.342e-06 |
1.71e-05 |
366 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
133 |
404 |
1.36e-06 |
1.729e-05 |
367 |
NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
190 |
616 |
1.406e-06 |
1.783e-05 |
368 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
98 |
279 |
1.435e-06 |
1.815e-05 |
369 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
55 |
134 |
1.549e-06 |
1.948e-05 |
370 |
INTERACTION WITH HOST |
55 |
134 |
1.549e-06 |
1.948e-05 |
371 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
122 |
365 |
1.557e-06 |
1.953e-05 |
372 |
NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION |
58 |
144 |
1.691e-06 |
2.115e-05 |
373 |
REGULATION OF FAT CELL DIFFERENTIATION |
46 |
106 |
1.754e-06 |
2.188e-05 |
374 |
AMEBOIDAL TYPE CELL MIGRATION |
61 |
154 |
1.79e-06 |
2.225e-05 |
375 |
REGULATION OF CELL CYCLE |
276 |
949 |
1.794e-06 |
2.225e-05 |
376 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
45 |
103 |
1.809e-06 |
2.239e-05 |
377 |
CELL CELL SIGNALING |
229 |
767 |
1.816e-06 |
2.242e-05 |
378 |
METENCEPHALON DEVELOPMENT |
44 |
100 |
1.859e-06 |
2.289e-05 |
379 |
RESPONSE TO ESTROGEN |
80 |
218 |
1.9e-06 |
2.327e-05 |
380 |
REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
80 |
218 |
1.9e-06 |
2.327e-05 |
381 |
PROTEIN LOCALIZATION TO CELL PERIPHERY |
60 |
151 |
1.919e-06 |
2.344e-05 |
382 |
MULTICELLULAR ORGANISMAL MACROMOLECULE METABOLIC PROCESS |
37 |
79 |
1.962e-06 |
2.39e-05 |
383 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
29 |
56 |
1.967e-06 |
2.39e-05 |
384 |
INTEGRIN MEDIATED SIGNALING PATHWAY |
38 |
82 |
1.983e-06 |
2.403e-05 |
385 |
CYTOSOLIC TRANSPORT |
79 |
215 |
2.074e-06 |
2.507e-05 |
386 |
REGULATION OF TRANSPORTER ACTIVITY |
74 |
198 |
2.086e-06 |
2.508e-05 |
387 |
GLYCOSYLATION |
94 |
267 |
2.082e-06 |
2.508e-05 |
388 |
CYTOSKELETON ORGANIZATION |
247 |
838 |
2.121e-06 |
2.544e-05 |
389 |
MAMMARY GLAND MORPHOGENESIS |
23 |
40 |
2.128e-06 |
2.546e-05 |
390 |
INTRACELLULAR RECEPTOR SIGNALING PATHWAY |
65 |
168 |
2.183e-06 |
2.605e-05 |
391 |
EAR DEVELOPMENT |
73 |
195 |
2.269e-06 |
2.694e-05 |
392 |
REGULATION OF MUSCLE SYSTEM PROCESS |
73 |
195 |
2.269e-06 |
2.694e-05 |
393 |
NEURON MIGRATION |
47 |
110 |
2.311e-06 |
2.737e-05 |
394 |
FOREBRAIN CELL MIGRATION |
31 |
62 |
2.338e-06 |
2.761e-05 |
395 |
OSTEOBLAST DIFFERENTIATION |
52 |
126 |
2.431e-06 |
2.863e-05 |
396 |
POSITIVE REGULATION OF FAT CELL DIFFERENTIATION |
27 |
51 |
2.535e-06 |
2.979e-05 |
397 |
MULTICELLULAR ORGANISMAL SIGNALING |
51 |
123 |
2.568e-06 |
3.002e-05 |
398 |
ENDOCRINE SYSTEM DEVELOPMENT |
51 |
123 |
2.568e-06 |
3.002e-05 |
399 |
ORGAN GROWTH |
33 |
68 |
2.611e-06 |
3.044e-05 |
400 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
43 |
98 |
2.65e-06 |
3.076e-05 |
401 |
CEREBRAL CORTEX CELL MIGRATION |
24 |
43 |
2.651e-06 |
3.076e-05 |
402 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
269 |
926 |
2.681e-06 |
3.103e-05 |
403 |
CANONICAL WNT SIGNALING PATHWAY |
42 |
95 |
2.718e-06 |
3.124e-05 |
404 |
ENDODERM DEVELOPMENT |
34 |
71 |
2.708e-06 |
3.124e-05 |
405 |
REGIONALIZATION |
106 |
311 |
2.719e-06 |
3.124e-05 |
406 |
REGULATION OF BMP SIGNALING PATHWAY |
36 |
77 |
2.83e-06 |
3.243e-05 |
407 |
RESPONSE TO ESTRADIOL |
58 |
146 |
2.848e-06 |
3.256e-05 |
408 |
REGULATION OF POTASSIUM ION TRANSPORT |
38 |
83 |
2.861e-06 |
3.263e-05 |
409 |
MAMMARY GLAND DUCT MORPHOGENESIS |
18 |
28 |
2.99e-06 |
3.402e-05 |
410 |
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
74 |
200 |
3.205e-06 |
3.638e-05 |
411 |
STRIATED MUSCLE CELL DIFFERENTIATION |
66 |
173 |
3.228e-06 |
3.645e-05 |
412 |
SIGNAL RELEASE |
66 |
173 |
3.228e-06 |
3.645e-05 |
413 |
NEGATIVE REGULATION OF TRANSPORT |
146 |
458 |
3.267e-06 |
3.681e-05 |
414 |
REGULATION OF CHEMOTAXIS |
68 |
180 |
3.443e-06 |
3.87e-05 |
415 |
NEGATIVE REGULATION OF CELL CYCLE |
139 |
433 |
3.688e-06 |
4.135e-05 |
416 |
REGULATION OF PROTEIN SECRETION |
127 |
389 |
3.743e-06 |
4.186e-05 |
417 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
309 |
1087 |
3.773e-06 |
4.21e-05 |
418 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
72 |
194 |
3.809e-06 |
4.23e-05 |
419 |
CELL SUBSTRATE JUNCTION ASSEMBLY |
23 |
41 |
3.806e-06 |
4.23e-05 |
420 |
PERIPHERAL NERVOUS SYSTEM DEVELOPMENT |
33 |
69 |
3.917e-06 |
4.34e-05 |
421 |
MOVEMENT IN ENVIRONMENT OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
39 |
87 |
4.037e-06 |
4.399e-05 |
422 |
ENTRY INTO CELL OF OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
39 |
87 |
4.037e-06 |
4.399e-05 |
423 |
VIRAL ENTRY INTO HOST CELL |
39 |
87 |
4.037e-06 |
4.399e-05 |
424 |
ENTRY INTO OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION |
39 |
87 |
4.037e-06 |
4.399e-05 |
425 |
MOVEMENT IN HOST ENVIRONMENT |
39 |
87 |
4.037e-06 |
4.399e-05 |
426 |
ENTRY INTO HOST |
39 |
87 |
4.037e-06 |
4.399e-05 |
427 |
ENTRY INTO HOST CELL |
39 |
87 |
4.037e-06 |
4.399e-05 |
428 |
CYTOKINESIS |
38 |
84 |
4.087e-06 |
4.443e-05 |
429 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
44 |
103 |
4.829e-06 |
5.237e-05 |
430 |
GASTRULATION |
60 |
155 |
5.174e-06 |
5.599e-05 |
431 |
POSITIVE REGULATION OF CATABOLIC PROCESS |
128 |
395 |
5.226e-06 |
5.642e-05 |
432 |
MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL |
22 |
39 |
5.462e-06 |
5.883e-05 |
433 |
POSITIVE REGULATION OF WNT SIGNALING PATHWAY |
59 |
152 |
5.586e-06 |
6.002e-05 |
434 |
REGULATION OF ORGAN GROWTH |
34 |
73 |
5.886e-06 |
6.31e-05 |
435 |
FORMATION OF PRIMARY GERM LAYER |
46 |
110 |
5.941e-06 |
6.34e-05 |
436 |
SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
116 |
352 |
5.932e-06 |
6.34e-05 |
437 |
ORGAN FORMATION |
20 |
34 |
6.114e-06 |
6.51e-05 |
438 |
EYE MORPHOGENESIS |
54 |
136 |
6.278e-06 |
6.67e-05 |
439 |
REGULATION OF EPITHELIAL CELL MIGRATION |
63 |
166 |
6.506e-06 |
6.895e-05 |
440 |
MUSCLE ORGAN DEVELOPMENT |
95 |
277 |
6.527e-06 |
6.903e-05 |
441 |
REGULATION OF PROTEIN IMPORT |
68 |
183 |
6.654e-06 |
7.02e-05 |
442 |
REGULATION OF BLOOD CIRCULATION |
100 |
295 |
6.694e-06 |
7.047e-05 |
443 |
POSITIVE REGULATION OF VASCULATURE DEVELOPMENT |
53 |
133 |
6.728e-06 |
7.066e-05 |
444 |
REGULATION OF NEUROTRANSMITTER LEVELS |
70 |
190 |
6.918e-06 |
7.25e-05 |
445 |
REGULATION OF IMMUNE SYSTEM PROCESS |
386 |
1403 |
7.508e-06 |
7.851e-05 |
446 |
CARDIAC MUSCLE CELL ACTION POTENTIAL |
21 |
37 |
7.832e-06 |
8.17e-05 |
447 |
EPITHELIAL CELL PROLIFERATION |
39 |
89 |
7.896e-06 |
8.219e-05 |
448 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
98 |
289 |
8.099e-06 |
8.412e-05 |
449 |
AMINO ACID TRANSPORT |
50 |
124 |
8.218e-06 |
8.517e-05 |
450 |
REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
57 |
147 |
8.282e-06 |
8.564e-05 |
451 |
SUBSTRATE DEPENDENT CELL MIGRATION |
17 |
27 |
8.564e-06 |
8.836e-05 |
452 |
REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
25 |
48 |
8.705e-06 |
8.961e-05 |
453 |
POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
64 |
171 |
9.357e-06 |
9.611e-05 |
454 |
REGENERATION |
61 |
161 |
9.616e-06 |
9.855e-05 |
455 |
LIPID PHOSPHORYLATION |
42 |
99 |
9.677e-06 |
9.896e-05 |
456 |
MULTICELLULAR ORGANISM METABOLIC PROCESS |
40 |
93 |
1.051e-05 |
0.0001073 |
457 |
REGULATION OF ENDOCYTOSIS |
72 |
199 |
1.07e-05 |
0.0001087 |
458 |
ORGANELLE LOCALIZATION |
132 |
415 |
1.069e-05 |
0.0001087 |
459 |
RESPONSE TO PEPTIDE |
129 |
404 |
1.087e-05 |
0.0001101 |
460 |
TISSUE REMODELING |
38 |
87 |
1.126e-05 |
0.0001139 |
461 |
STEM CELL PROLIFERATION |
29 |
60 |
1.15e-05 |
0.0001158 |
462 |
CHONDROCYTE DIFFERENTIATION |
29 |
60 |
1.15e-05 |
0.0001158 |
463 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
37 |
84 |
1.158e-05 |
0.0001164 |
464 |
LUNG CELL DIFFERENTIATION |
16 |
25 |
1.173e-05 |
0.0001176 |
465 |
LENS DEVELOPMENT IN CAMERA TYPE EYE |
31 |
66 |
1.212e-05 |
0.0001212 |
466 |
PROTEIN N LINKED GLYCOSYLATION |
34 |
75 |
1.221e-05 |
0.0001217 |
467 |
OSTEOCLAST DIFFERENTIATION |
18 |
30 |
1.222e-05 |
0.0001217 |
468 |
SYNAPSE ASSEMBLY |
32 |
69 |
1.225e-05 |
0.0001218 |
469 |
PLATELET ACTIVATION |
55 |
142 |
1.228e-05 |
0.0001219 |
470 |
POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS |
90 |
263 |
1.243e-05 |
0.000123 |
471 |
PHOSPHATIDYLINOSITOL METABOLIC PROCESS |
70 |
193 |
1.281e-05 |
0.0001265 |
472 |
PROTEIN SECRETION |
47 |
116 |
1.302e-05 |
0.0001284 |
473 |
REGULATION OF JNK CASCADE |
60 |
159 |
1.309e-05 |
0.0001287 |
474 |
POSITIVE REGULATION OF CELL ADHESION |
121 |
376 |
1.343e-05 |
0.0001318 |
475 |
GLOMERULUS DEVELOPMENT |
25 |
49 |
1.395e-05 |
0.0001361 |
476 |
REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
25 |
49 |
1.395e-05 |
0.0001361 |
477 |
CARDIAC SEPTUM MORPHOGENESIS |
25 |
49 |
1.395e-05 |
0.0001361 |
478 |
RESPONSE TO BMP |
40 |
94 |
1.431e-05 |
0.0001391 |
479 |
CELLULAR RESPONSE TO BMP STIMULUS |
40 |
94 |
1.431e-05 |
0.0001391 |
480 |
CELL PROJECTION ASSEMBLY |
90 |
264 |
1.47e-05 |
0.0001425 |
481 |
INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
11 |
14 |
1.491e-05 |
0.0001443 |
482 |
REGULATION OF STEM CELL PROLIFERATION |
38 |
88 |
1.551e-05 |
0.0001497 |
483 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
27 |
55 |
1.597e-05 |
0.0001539 |
484 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
37 |
85 |
1.605e-05 |
0.0001543 |
485 |
LUNG ALVEOLUS DEVELOPMENT |
22 |
41 |
1.617e-05 |
0.0001551 |
486 |
CARDIAC CONDUCTION |
36 |
82 |
1.654e-05 |
0.0001583 |
487 |
REGULATION OF RECEPTOR ACTIVITY |
47 |
117 |
1.701e-05 |
0.0001626 |
488 |
MEMBRANE DEPOLARIZATION |
29 |
61 |
1.719e-05 |
0.0001629 |
489 |
VENTRICULAR SEPTUM MORPHOGENESIS |
17 |
28 |
1.718e-05 |
0.0001629 |
490 |
POSITIVE REGULATION OF SYNAPSE ASSEMBLY |
29 |
61 |
1.719e-05 |
0.0001629 |
491 |
REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT |
29 |
61 |
1.719e-05 |
0.0001629 |
492 |
PANCREAS DEVELOPMENT |
33 |
73 |
1.755e-05 |
0.0001653 |
493 |
REGULATION OF PLASMA MEMBRANE ORGANIZATION |
33 |
73 |
1.755e-05 |
0.0001653 |
494 |
MICROTUBULE BASED MOVEMENT |
73 |
205 |
1.753e-05 |
0.0001653 |
495 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
31 |
67 |
1.767e-05 |
0.0001661 |
496 |
CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS |
68 |
188 |
1.873e-05 |
0.0001757 |
497 |
CELL CYCLE |
361 |
1316 |
1.973e-05 |
0.0001848 |
498 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
48 |
121 |
2.061e-05 |
0.0001926 |
499 |
PROTEIN COMPLEX SUBUNIT ORGANIZATION |
413 |
1527 |
2.079e-05 |
0.0001939 |
500 |
ANION TRANSPORT |
155 |
507 |
2.152e-05 |
0.0002003 |
501 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
25 |
50 |
2.19e-05 |
0.000203 |
502 |
ENDODERM FORMATION |
25 |
50 |
2.19e-05 |
0.000203 |
503 |
POSITIVE REGULATION OF CELL GROWTH |
56 |
148 |
2.283e-05 |
0.0002106 |
504 |
MYELOID CELL DIFFERENTIATION |
68 |
189 |
2.283e-05 |
0.0002106 |
505 |
POSITIVE REGULATION OF CELL CYCLE |
108 |
332 |
2.286e-05 |
0.0002106 |
506 |
MESONEPHRIC TUBULE MORPHOGENESIS |
26 |
53 |
2.32e-05 |
0.0002134 |
507 |
NEGATIVE CHEMOTAXIS |
21 |
39 |
2.345e-05 |
0.0002152 |
508 |
REGULATION OF AUTOPHAGY |
85 |
249 |
2.366e-05 |
0.0002167 |
509 |
REGULATION OF CELL PROJECTION ASSEMBLY |
58 |
155 |
2.413e-05 |
0.0002205 |
510 |
REGULATION OF DENDRITIC SPINE DEVELOPMENT |
27 |
56 |
2.42e-05 |
0.0002208 |
511 |
ACTOMYOSIN STRUCTURE ORGANIZATION |
34 |
77 |
2.426e-05 |
0.0002209 |
512 |
CARDIAC MUSCLE CELL DIFFERENTIATION |
33 |
74 |
2.481e-05 |
0.0002254 |
513 |
POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
29 |
62 |
2.532e-05 |
0.0002297 |
514 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
73 |
207 |
2.553e-05 |
0.0002311 |
515 |
REGULATION OF HEART GROWTH |
22 |
42 |
2.669e-05 |
0.0002411 |
516 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
39 |
93 |
2.732e-05 |
0.0002463 |
517 |
POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION |
13 |
19 |
2.795e-05 |
0.0002516 |
518 |
POSITIVE REGULATION OF PROTEOLYSIS |
116 |
363 |
2.832e-05 |
0.0002544 |
519 |
GLYCEROPHOSPHOLIPID METABOLIC PROCESS |
98 |
297 |
2.849e-05 |
0.0002554 |
520 |
POSITIVE REGULATION OF SODIUM ION TRANSPORT |
19 |
34 |
2.865e-05 |
0.0002558 |
521 |
REGULATION OF MESENCHYMAL CELL PROLIFERATION |
19 |
34 |
2.865e-05 |
0.0002558 |
522 |
POSITIVE REGULATION OF ION TRANSPORT |
81 |
236 |
2.922e-05 |
0.0002601 |
523 |
TUBE FORMATION |
50 |
129 |
2.923e-05 |
0.0002601 |
524 |
FEMALE SEX DIFFERENTIATION |
46 |
116 |
3.067e-05 |
0.0002723 |
525 |
INORGANIC ION TRANSMEMBRANE TRANSPORT |
174 |
583 |
3.142e-05 |
0.0002785 |
526 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
41 |
100 |
3.259e-05 |
0.0002883 |
527 |
POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT |
17 |
29 |
3.272e-05 |
0.0002889 |
528 |
REGULATION OF ANOIKIS |
15 |
24 |
3.347e-05 |
0.0002944 |
529 |
CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION |
15 |
24 |
3.347e-05 |
0.0002944 |
530 |
ARTERY MORPHOGENESIS |
25 |
51 |
3.373e-05 |
0.0002961 |
531 |
CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION |
20 |
37 |
3.401e-05 |
0.000298 |
532 |
POSITIVE REGULATION OF SYNAPTIC TRANSMISSION |
44 |
110 |
3.523e-05 |
0.0003082 |
533 |
NEGATIVE REGULATION OF ANOIKIS |
12 |
17 |
3.585e-05 |
0.0003123 |
534 |
INTESTINAL EPITHELIAL CELL DIFFERENTIATION |
12 |
17 |
3.585e-05 |
0.0003123 |
535 |
FORELIMB MORPHOGENESIS |
21 |
40 |
3.882e-05 |
0.0003364 |
536 |
ENDODERMAL CELL DIFFERENTIATION |
21 |
40 |
3.882e-05 |
0.0003364 |
537 |
REGULATION OF NEURON DEATH |
85 |
252 |
3.879e-05 |
0.0003364 |
538 |
LEUKOCYTE ACTIVATION |
129 |
414 |
3.936e-05 |
0.0003405 |
539 |
POSITIVE REGULATION OF BINDING |
49 |
127 |
4.017e-05 |
0.0003467 |
540 |
CELL CYCLE ARREST |
57 |
154 |
4.053e-05 |
0.0003492 |
541 |
REGULATION OF NEURON APOPTOTIC PROCESS |
68 |
192 |
4.065e-05 |
0.0003496 |
542 |
CELLULAR RESPONSE TO PEPTIDE |
91 |
274 |
4.106e-05 |
0.0003525 |
543 |
REGULATION OF PEPTIDE TRANSPORT |
86 |
256 |
4.14e-05 |
0.0003548 |
544 |
REGULATION OF EMBRYONIC DEVELOPMENT |
45 |
114 |
4.25e-05 |
0.0003635 |
545 |
CAMERA TYPE EYE MORPHOGENESIS |
41 |
101 |
4.292e-05 |
0.0003664 |
546 |
REGULATION OF PROTEIN BINDING |
61 |
168 |
4.305e-05 |
0.0003669 |
547 |
CELLULAR RESPONSE TO ACID CHEMICAL |
63 |
175 |
4.385e-05 |
0.000373 |
548 |
PROTEIN OLIGOMERIZATION |
134 |
434 |
4.549e-05 |
0.0003863 |
549 |
ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY |
53 |
141 |
4.594e-05 |
0.0003894 |
550 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
78 |
228 |
4.607e-05 |
0.0003898 |
551 |
DENDRITE DEVELOPMENT |
34 |
79 |
4.633e-05 |
0.0003899 |
552 |
CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS |
14 |
22 |
4.623e-05 |
0.0003899 |
553 |
BONE MORPHOGENESIS |
34 |
79 |
4.633e-05 |
0.0003899 |
554 |
POSITIVE REGULATION OF HEART GROWTH |
16 |
27 |
4.657e-05 |
0.0003911 |
555 |
LEARNING |
50 |
131 |
4.692e-05 |
0.0003927 |
556 |
RETINA DEVELOPMENT IN CAMERA TYPE EYE |
50 |
131 |
4.692e-05 |
0.0003927 |
557 |
PEPTIDYL TYROSINE MODIFICATION |
66 |
186 |
4.895e-05 |
0.0004089 |
558 |
NEUROTRANSMITTER TRANSPORT |
57 |
155 |
5.007e-05 |
0.0004175 |
559 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
31 |
70 |
5.097e-05 |
0.0004242 |
560 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
30 |
67 |
5.204e-05 |
0.0004324 |
561 |
NEGATIVE REGULATION OF GROWTH |
80 |
236 |
5.315e-05 |
0.0004408 |
562 |
CELL GROWTH |
51 |
135 |
5.433e-05 |
0.0004498 |
563 |
INTESTINAL EPITHELIAL CELL DEVELOPMENT |
9 |
11 |
5.578e-05 |
0.000461 |
564 |
AMINOGLYCAN METABOLIC PROCESS |
60 |
166 |
5.761e-05 |
0.0004753 |
565 |
RESPONSE TO ENDOPLASMIC RETICULUM STRESS |
79 |
233 |
5.848e-05 |
0.0004816 |
566 |
REGULATION OF HEART RATE BY CARDIAC CONDUCTION |
17 |
30 |
5.954e-05 |
0.0004895 |
567 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION |
47 |
122 |
5.967e-05 |
0.0004896 |
568 |
POSITIVE REGULATION OF CELL SUBSTRATE ADHESION |
40 |
99 |
5.998e-05 |
0.0004913 |
569 |
NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE |
21 |
41 |
6.26e-05 |
0.000511 |
570 |
NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
21 |
41 |
6.26e-05 |
0.000511 |
571 |
BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS |
13 |
20 |
6.32e-05 |
0.000515 |
572 |
NEGATIVE REGULATION OF CELL GROWTH |
61 |
170 |
6.407e-05 |
0.0005198 |
573 |
MYELOID LEUKOCYTE DIFFERENTIATION |
39 |
96 |
6.395e-05 |
0.0005198 |
574 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
49 |
129 |
6.413e-05 |
0.0005198 |
575 |
CELLULAR RESPONSE TO OXIDATIVE STRESS |
65 |
184 |
6.483e-05 |
0.0005246 |
576 |
DEVELOPMENTAL CELL GROWTH |
33 |
77 |
6.591e-05 |
0.0005324 |
577 |
REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
15 |
25 |
6.608e-05 |
0.0005329 |
578 |
REGULATION OF DENDRITE MORPHOGENESIS |
32 |
74 |
6.853e-05 |
0.0005517 |
579 |
EMBRYONIC DIGESTIVE TRACT DEVELOPMENT |
18 |
33 |
7.162e-05 |
0.0005745 |
580 |
NEGATIVE REGULATION OF JNK CASCADE |
18 |
33 |
7.162e-05 |
0.0005745 |
581 |
CELL CYCLE PROCESS |
298 |
1081 |
7.21e-05 |
0.0005774 |
582 |
ENDOTHELIUM DEVELOPMENT |
37 |
90 |
7.227e-05 |
0.0005778 |
583 |
NEGATIVE REGULATION OF AXONOGENESIS |
29 |
65 |
7.474e-05 |
0.0005965 |
584 |
APOPTOTIC SIGNALING PATHWAY |
94 |
289 |
7.525e-05 |
0.0005995 |
585 |
REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE |
25 |
53 |
7.583e-05 |
0.0006011 |
586 |
CYTOSOLIC CALCIUM ION TRANSPORT |
25 |
53 |
7.583e-05 |
0.0006011 |
587 |
CELLULAR RESPONSE TO AMINO ACID STIMULUS |
25 |
53 |
7.583e-05 |
0.0006011 |
588 |
RESPONSE TO OXIDATIVE STRESS |
111 |
352 |
7.689e-05 |
0.0006085 |
589 |
NEGATIVE REGULATION OF NEURON DEATH |
61 |
171 |
7.779e-05 |
0.0006145 |
590 |
SEMAPHORIN PLEXIN SIGNALING PATHWAY |
19 |
36 |
8.229e-05 |
0.000649 |
591 |
ESTABLISHMENT OF LOCALIZATION BY MOVEMENT ALONG MICROTUBULE |
39 |
97 |
8.373e-05 |
0.0006592 |
592 |
PHOSPHOLIPID METABOLIC PROCESS |
114 |
364 |
8.513e-05 |
0.0006691 |
593 |
REGULATION OF HEART CONTRACTION |
75 |
221 |
8.576e-05 |
0.0006718 |
594 |
REGULATION OF KERATINOCYTE PROLIFERATION |
16 |
28 |
8.576e-05 |
0.0006718 |
595 |
REGULATION OF AXON GUIDANCE |
20 |
39 |
9.129e-05 |
0.0007115 |
596 |
ANATOMICAL STRUCTURE MATURATION |
20 |
39 |
9.129e-05 |
0.0007115 |
597 |
CYTOSKELETON DEPENDENT CYTOKINESIS |
20 |
39 |
9.129e-05 |
0.0007115 |
598 |
DEVELOPMENTAL MATURATION |
67 |
193 |
9.274e-05 |
0.0007216 |
599 |
REGULATION OF EXOCYTOSIS |
65 |
186 |
9.366e-05 |
0.0007266 |
600 |
ODONTOGENESIS OF DENTIN CONTAINING TOOTH |
32 |
75 |
9.37e-05 |
0.0007266 |
601 |
POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
63 |
179 |
9.415e-05 |
0.0007289 |
602 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
176 |
602 |
9.672e-05 |
0.0007476 |
603 |
ENDOTHELIAL CELL DIFFERENTIATION |
31 |
72 |
9.766e-05 |
0.0007536 |
604 |
CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
70 |
204 |
9.88e-05 |
0.0007611 |
605 |
RESPONSE TO INORGANIC SUBSTANCE |
144 |
479 |
0.0001006 |
0.0007737 |
606 |
EXOCRINE SYSTEM DEVELOPMENT |
22 |
45 |
0.000104 |
0.0007983 |
607 |
REGULATION OF HORMONE SECRETION |
86 |
262 |
0.0001044 |
0.0007992 |
608 |
REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING |
78 |
233 |
0.0001045 |
0.0007992 |
609 |
REGULATION OF CARDIAC MUSCLE CONTRACTION |
29 |
66 |
0.0001046 |
0.0007992 |
610 |
REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
23 |
48 |
0.0001078 |
0.0008219 |
611 |
REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
118 |
381 |
0.0001088 |
0.0008278 |
612 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
39 |
98 |
0.0001089 |
0.0008278 |
613 |
ORGANELLE TRANSPORT ALONG MICROTUBULE |
27 |
60 |
0.0001094 |
0.0008305 |
614 |
NEURAL CREST CELL MIGRATION |
24 |
51 |
0.00011 |
0.0008323 |
615 |
SEX DIFFERENTIATION |
87 |
266 |
0.0001099 |
0.0008323 |
616 |
APOPTOTIC MITOCHONDRIAL CHANGES |
26 |
57 |
0.0001107 |
0.0008359 |
617 |
NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION |
11 |
16 |
0.0001127 |
0.0008457 |
618 |
POSITIVE REGULATION OF INTRACELLULAR TRANSPORT |
115 |
370 |
0.0001126 |
0.0008457 |
619 |
NEURON CELL CELL ADHESION |
11 |
16 |
0.0001127 |
0.0008457 |
620 |
MAGNESIUM ION TRANSMEMBRANE TRANSPORT |
11 |
16 |
0.0001127 |
0.0008457 |
621 |
PROTEIN HOMOOLIGOMERIZATION |
82 |
248 |
0.0001134 |
0.0008498 |
622 |
PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
18 |
34 |
0.00012 |
0.0008931 |
623 |
ADHERENS JUNCTION ASSEMBLY |
18 |
34 |
0.00012 |
0.0008931 |
624 |
HEART VALVE DEVELOPMENT |
18 |
34 |
0.00012 |
0.0008931 |
625 |
CAMP METABOLIC PROCESS |
18 |
34 |
0.00012 |
0.0008931 |
626 |
SYNAPTIC SIGNALING |
129 |
424 |
0.0001281 |
0.000952 |
627 |
RENAL SYSTEM PROCESS |
40 |
102 |
0.0001306 |
0.0009692 |
628 |
CHONDROCYTE DEVELOPMENT |
13 |
21 |
0.0001313 |
0.00097 |
629 |
LIPID TRANSLOCATION |
13 |
21 |
0.0001313 |
0.00097 |
630 |
ACIDIC AMINO ACID TRANSPORT |
13 |
21 |
0.0001313 |
0.00097 |
631 |
MUSCLE SYSTEM PROCESS |
91 |
282 |
0.0001331 |
0.0009816 |
632 |
POST EMBRYONIC DEVELOPMENT |
36 |
89 |
0.0001335 |
0.000983 |
633 |
LOCOMOTORY BEHAVIOR |
63 |
181 |
0.0001355 |
0.0009961 |
634 |
AGING |
86 |
264 |
0.00014 |
0.001027 |
635 |
ORGANIC ANION TRANSPORT |
119 |
387 |
0.0001419 |
0.00104 |
636 |
NEGATIVE REGULATION OF JUN KINASE ACTIVITY |
10 |
14 |
0.0001448 |
0.001059 |
637 |
POSITIVE REGULATION OF DENDRITE DEVELOPMENT |
28 |
64 |
0.0001498 |
0.001094 |
638 |
EMBRYONIC DIGIT MORPHOGENESIS |
27 |
61 |
0.0001541 |
0.001122 |
639 |
MULTICELLULAR ORGANISMAL HOMEOSTASIS |
88 |
272 |
0.0001539 |
0.001122 |
640 |
EMBRYONIC CRANIAL SKELETON MORPHOGENESIS |
22 |
46 |
0.0001568 |
0.00114 |
641 |
L AMINO ACID TRANSPORT |
26 |
58 |
0.0001575 |
0.001142 |
642 |
EMBRYONIC PATTERN SPECIFICATION |
26 |
58 |
0.0001575 |
0.001142 |
643 |
ACTIVATION OF MAPKK ACTIVITY |
24 |
52 |
0.0001606 |
0.001162 |
644 |
REGULATION OF MUSCLE CONTRACTION |
53 |
147 |
0.0001625 |
0.001174 |
645 |
EMBRYONIC FORELIMB MORPHOGENESIS |
17 |
32 |
0.000175 |
0.001261 |
646 |
ADIPOSE TISSUE DEVELOPMENT |
17 |
32 |
0.000175 |
0.001261 |
647 |
ORGANOPHOSPHATE METABOLIC PROCESS |
246 |
885 |
0.0001755 |
0.001262 |
648 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
31 |
74 |
0.0001797 |
0.00129 |
649 |
REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY |
12 |
19 |
0.0001834 |
0.001315 |
650 |
NEGATIVE REGULATION OF WNT SIGNALING PATHWAY |
67 |
197 |
0.0001847 |
0.001322 |
651 |
ADHERENS JUNCTION ORGANIZATION |
30 |
71 |
0.000189 |
0.001351 |
652 |
RESPONSE TO METAL ION |
104 |
333 |
0.0001907 |
0.001361 |
653 |
REGULATION OF PROTEIN TARGETING |
97 |
307 |
0.0001942 |
0.001384 |
654 |
RESPONSE TO TRANSITION METAL NANOPARTICLE |
53 |
148 |
0.0001979 |
0.001408 |
655 |
HEMOSTASIS |
98 |
311 |
0.0002012 |
0.001429 |
656 |
REGULATION OF HORMONE LEVELS |
142 |
478 |
0.0002027 |
0.001438 |
657 |
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
19 |
38 |
0.00021 |
0.001481 |
658 |
REGULATION OF ACTION POTENTIAL |
19 |
38 |
0.00021 |
0.001481 |
659 |
CALCIUM ION TRANSPORT |
74 |
223 |
0.00021 |
0.001481 |
660 |
POSITIVE REGULATION OF ORGAN GROWTH |
19 |
38 |
0.00021 |
0.001481 |
661 |
POSITIVE REGULATION OF PROTEIN IMPORT |
40 |
104 |
0.0002127 |
0.001497 |
662 |
RESPONSE TO ACID CHEMICAL |
100 |
319 |
0.0002154 |
0.001514 |
663 |
REGULATION OF CARDIAC MUSCLE CELL CONTRACTION |
15 |
27 |
0.0002194 |
0.001522 |
664 |
REGULATION OF MUSCLE CELL DIFFERENTIATION |
54 |
152 |
0.0002187 |
0.001522 |
665 |
REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
15 |
27 |
0.0002194 |
0.001522 |
666 |
INTRINSIC APOPTOTIC SIGNALING PATHWAY |
54 |
152 |
0.0002187 |
0.001522 |
667 |
REGULATION OF CATENIN IMPORT INTO NUCLEUS |
15 |
27 |
0.0002194 |
0.001522 |
668 |
POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION |
15 |
27 |
0.0002194 |
0.001522 |
669 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS |
15 |
27 |
0.0002194 |
0.001522 |
670 |
CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS |
15 |
27 |
0.0002194 |
0.001522 |
671 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
72 |
216 |
0.000218 |
0.001522 |
672 |
POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT |
90 |
282 |
0.0002213 |
0.001526 |
673 |
REGULATION OF MEMBRANE DEPOLARIZATION |
20 |
41 |
0.0002211 |
0.001526 |
674 |
PROSTATE GLAND DEVELOPMENT |
20 |
41 |
0.0002211 |
0.001526 |
675 |
LACTATION |
20 |
41 |
0.0002211 |
0.001526 |
676 |
CARBOHYDRATE METABOLIC PROCESS |
189 |
662 |
0.0002222 |
0.00153 |
677 |
NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION |
70 |
209 |
0.0002257 |
0.001549 |
678 |
REGULATION OF PEPTIDE SECRETION |
70 |
209 |
0.0002257 |
0.001549 |
679 |
IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE |
25 |
56 |
0.0002268 |
0.001554 |
680 |
REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA |
21 |
44 |
0.0002282 |
0.001562 |
681 |
LYMPHOCYTE ACTIVATION |
106 |
342 |
0.0002292 |
0.001566 |
682 |
NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION |
24 |
53 |
0.0002307 |
0.001572 |
683 |
POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
24 |
53 |
0.0002307 |
0.001572 |
684 |
CELLULAR RESPONSE TO CAMP |
23 |
50 |
0.0002326 |
0.00158 |
685 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
23 |
50 |
0.0002326 |
0.00158 |
686 |
NEURAL TUBE DEVELOPMENT |
53 |
149 |
0.0002402 |
0.001627 |
687 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
71 |
213 |
0.00024 |
0.001627 |
688 |
ESTABLISHMENT OF CELL POLARITY |
35 |
88 |
0.0002429 |
0.001643 |
689 |
VESICLE LOCALIZATION |
74 |
224 |
0.0002448 |
0.001653 |
690 |
NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION |
38 |
98 |
0.0002493 |
0.001681 |
691 |
REGULATION OF NEURON MIGRATION |
16 |
30 |
0.0002556 |
0.001716 |
692 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION |
16 |
30 |
0.0002556 |
0.001716 |
693 |
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS |
16 |
30 |
0.0002556 |
0.001716 |
694 |
NEGATIVE REGULATION OF KINASE ACTIVITY |
81 |
250 |
0.0002609 |
0.001749 |
695 |
CELLULAR RESPONSE TO ALCOHOL |
43 |
115 |
0.0002617 |
0.001752 |
696 |
CELLULAR RESPONSE TO INSULIN STIMULUS |
52 |
146 |
0.0002637 |
0.001763 |
697 |
HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES |
54 |
153 |
0.0002643 |
0.001764 |
698 |
CARBOHYDRATE TRANSPORT |
37 |
95 |
0.0002695 |
0.001797 |
699 |
POSITIVE REGULATION OF SECRETION |
113 |
370 |
0.0002757 |
0.001835 |
700 |
CELLULAR RESPONSE TO STEROID HORMONE STIMULUS |
72 |
218 |
0.0002969 |
0.001973 |
701 |
ANION TRANSMEMBRANE TRANSPORT |
81 |
251 |
0.0003006 |
0.001995 |
702 |
NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
18 |
36 |
0.0003072 |
0.00203 |
703 |
POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION |
26 |
60 |
0.0003068 |
0.00203 |
704 |
POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS |
18 |
36 |
0.0003072 |
0.00203 |
705 |
RESPONSE TO CARBOHYDRATE |
58 |
168 |
0.0003111 |
0.002054 |
706 |
GLIAL CELL DEVELOPMENT |
31 |
76 |
0.0003184 |
0.002096 |
707 |
PROTEIN DEPOLYMERIZATION |
14 |
25 |
0.0003189 |
0.002096 |
708 |
HISTONE PHOSPHORYLATION |
14 |
25 |
0.0003189 |
0.002096 |
709 |
VESICLE CYTOSKELETAL TRAFFICKING |
19 |
39 |
0.0003228 |
0.002113 |
710 |
TRABECULA MORPHOGENESIS |
19 |
39 |
0.0003228 |
0.002113 |
711 |
LONG TERM SYNAPTIC POTENTIATION |
19 |
39 |
0.0003228 |
0.002113 |
712 |
MONOSACCHARIDE TRANSPORT |
24 |
54 |
0.0003266 |
0.002134 |
713 |
DENDRITE MORPHOGENESIS |
20 |
42 |
0.0003325 |
0.002167 |
714 |
NEGATIVE REGULATION OF BMP SIGNALING PATHWAY |
20 |
42 |
0.0003325 |
0.002167 |
715 |
REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
59 |
172 |
0.0003363 |
0.002189 |
716 |
COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT |
22 |
48 |
0.0003369 |
0.002189 |
717 |
EMBRYONIC HEART TUBE DEVELOPMENT |
30 |
73 |
0.0003387 |
0.002198 |
718 |
MICROTUBULE BASED PROCESS |
152 |
522 |
0.0003412 |
0.002211 |
719 |
EPITHELIAL CELL MATURATION |
10 |
15 |
0.0003456 |
0.002236 |
720 |
AMELOGENESIS |
12 |
20 |
0.0003637 |
0.002347 |
721 |
REGULATION OF MACROPHAGE DIFFERENTIATION |
12 |
20 |
0.0003637 |
0.002347 |
722 |
REGULATION OF CIRCADIAN RHYTHM |
39 |
103 |
0.0003683 |
0.002371 |
723 |
POSITIVE REGULATION OF CHEMOTAXIS |
44 |
120 |
0.0003684 |
0.002371 |
724 |
PEPTIDYL TYROSINE DEPHOSPHORYLATION |
38 |
100 |
0.0004006 |
0.002575 |
725 |
MITOTIC CYTOKINESIS |
16 |
31 |
0.0004173 |
0.002678 |
726 |
ANTIGEN PROCESSING AND PRESENTATION |
70 |
213 |
0.0004189 |
0.002685 |
727 |
PROTEIN STABILIZATION |
47 |
131 |
0.0004201 |
0.002686 |
728 |
POSITIVE REGULATION OF STEM CELL PROLIFERATION |
26 |
61 |
0.0004202 |
0.002686 |
729 |
PHOSPHOLIPID BIOSYNTHETIC PROCESS |
76 |
235 |
0.0004214 |
0.00269 |
730 |
REGULATION OF SEQUESTERING OF CALCIUM ION |
40 |
107 |
0.0004234 |
0.002691 |
731 |
NEGATIVE REGULATION OF MAPK CASCADE |
51 |
145 |
0.0004229 |
0.002691 |
732 |
AMINOGLYCAN BIOSYNTHETIC PROCESS |
40 |
107 |
0.0004234 |
0.002691 |
733 |
POSITIVE REGULATION OF ENDOCYTOSIS |
42 |
114 |
0.0004408 |
0.002798 |
734 |
CELL CELL JUNCTION ASSEMBLY |
30 |
74 |
0.0004472 |
0.002831 |
735 |
RESPONSE TO CYTOKINE |
200 |
714 |
0.000447 |
0.002831 |
736 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS |
24 |
55 |
0.0004557 |
0.002877 |
737 |
REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL |
24 |
55 |
0.0004557 |
0.002877 |
738 |
PROTEIN ALPHA 1 2 DEMANNOSYLATION |
9 |
13 |
0.0004609 |
0.00289 |
739 |
MAGNESIUM ION TRANSPORT |
9 |
13 |
0.0004609 |
0.00289 |
740 |
PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
9 |
13 |
0.0004609 |
0.00289 |
741 |
PROTEIN DEMANNOSYLATION |
9 |
13 |
0.0004609 |
0.00289 |
742 |
PERIPHERAL NERVOUS SYSTEM NEURON DEVELOPMENT |
9 |
13 |
0.0004609 |
0.00289 |
743 |
RESPONSE TO INCREASED OXYGEN LEVELS |
13 |
23 |
0.0004634 |
0.002891 |
744 |
REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING |
13 |
23 |
0.0004634 |
0.002891 |
745 |
RESPONSE TO HYPEROXIA |
13 |
23 |
0.0004634 |
0.002891 |
746 |
INNERVATION |
13 |
23 |
0.0004634 |
0.002891 |
747 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
48 |
135 |
0.0004647 |
0.002895 |
748 |
REGULATION OF MEMBRANE LIPID DISTRIBUTION |
18 |
37 |
0.0004719 |
0.00292 |
749 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY |
18 |
37 |
0.0004719 |
0.00292 |
750 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
18 |
37 |
0.0004719 |
0.00292 |
751 |
ACTIN FILAMENT ORGANIZATION |
59 |
174 |
0.0004717 |
0.00292 |
752 |
IMPORT INTO CELL |
18 |
37 |
0.0004719 |
0.00292 |
753 |
DICARBOXYLIC ACID TRANSPORT |
29 |
71 |
0.000477 |
0.002944 |
754 |
BODY FLUID SECRETION |
29 |
71 |
0.000477 |
0.002944 |
755 |
HINDBRAIN MORPHOGENESIS |
19 |
40 |
0.0004848 |
0.002988 |
756 |
GLYCEROLIPID METABOLIC PROCESS |
108 |
356 |
0.0004858 |
0.00299 |
757 |
POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS |
238 |
867 |
0.000488 |
0.002999 |
758 |
MORPHOGENESIS OF AN EPITHELIAL SHEET |
20 |
43 |
0.0004898 |
0.003007 |
759 |
PROTEIN TARGETING |
121 |
406 |
0.0005013 |
0.003073 |
760 |
REGULATION OF CELL JUNCTION ASSEMBLY |
28 |
68 |
0.0005075 |
0.003107 |
761 |
REGULATION OF COLLATERAL SPROUTING |
11 |
18 |
0.0005181 |
0.003159 |
762 |
RESPONSE TO EXTRACELLULAR STIMULUS |
130 |
441 |
0.000518 |
0.003159 |
763 |
CENTROSOME LOCALIZATION |
11 |
18 |
0.0005181 |
0.003159 |
764 |
REGULATION OF CATION CHANNEL ACTIVITY |
34 |
88 |
0.0005562 |
0.003387 |
765 |
RAS PROTEIN SIGNAL TRANSDUCTION |
50 |
143 |
0.0005593 |
0.003402 |
766 |
CARDIAC VENTRICLE MORPHOGENESIS |
26 |
62 |
0.0005689 |
0.003451 |
767 |
EMBRYONIC HEART TUBE MORPHOGENESIS |
26 |
62 |
0.0005689 |
0.003451 |
768 |
REGULATION OF LIPID METABOLIC PROCESS |
88 |
282 |
0.0005839 |
0.003538 |
769 |
BONE TRABECULA MORPHOGENESIS |
8 |
11 |
0.0005937 |
0.003578 |
770 |
NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
8 |
11 |
0.0005937 |
0.003578 |
771 |
POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY |
8 |
11 |
0.0005937 |
0.003578 |
772 |
NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
8 |
11 |
0.0005937 |
0.003578 |
773 |
RESPONSE TO AMINO ACID |
41 |
112 |
0.0005955 |
0.003584 |
774 |
POTASSIUM ION TRANSPORT |
53 |
154 |
0.0005993 |
0.003603 |
775 |
PROTEIN DEPHOSPHORYLATION |
63 |
190 |
0.0006081 |
0.003651 |
776 |
STEM CELL DIVISION |
15 |
29 |
0.0006122 |
0.003661 |
777 |
POSITIVE REGULATION OF CARTILAGE DEVELOPMENT |
15 |
29 |
0.0006122 |
0.003661 |
778 |
CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION |
15 |
29 |
0.0006122 |
0.003661 |
779 |
NEGATIVE REGULATION OF CELL ADHESION |
72 |
223 |
0.0006189 |
0.003697 |
780 |
CIRCULATORY SYSTEM PROCESS |
110 |
366 |
0.0006308 |
0.003763 |
781 |
RESPONSE TO HYDROGEN PEROXIDE |
40 |
109 |
0.0006519 |
0.003884 |
782 |
SALIVARY GLAND DEVELOPMENT |
16 |
32 |
0.0006596 |
0.00391 |
783 |
METANEPHRIC NEPHRON DEVELOPMENT |
16 |
32 |
0.0006596 |
0.00391 |
784 |
POSITIVE REGULATION OF DENDRITE MORPHOGENESIS |
16 |
32 |
0.0006596 |
0.00391 |
785 |
REGULATION OF ACTIN FILAMENT BASED MOVEMENT |
16 |
32 |
0.0006596 |
0.00391 |
786 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT |
42 |
116 |
0.0006676 |
0.003952 |
787 |
CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS |
78 |
246 |
0.0006921 |
0.004092 |
788 |
REGULATION OF STRIATED MUSCLE CONTRACTION |
31 |
79 |
0.0007037 |
0.004155 |
789 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
20 |
44 |
0.0007078 |
0.004174 |
790 |
RESPONSE TO REACTIVE OXYGEN SPECIES |
63 |
191 |
0.0007091 |
0.004177 |
791 |
SYNAPTIC VESICLE LOCALIZATION |
39 |
106 |
0.0007136 |
0.004182 |
792 |
AORTA DEVELOPMENT |
19 |
41 |
0.0007126 |
0.004182 |
793 |
REGULATION OF GLUCOSE METABOLIC PROCESS |
39 |
106 |
0.0007136 |
0.004182 |
794 |
EXOCYTOSIS |
95 |
310 |
0.0007118 |
0.004182 |
795 |
REGULATION OF PROTEIN COMPLEX ASSEMBLY |
112 |
375 |
0.0007279 |
0.00426 |
796 |
OVULATION CYCLE |
41 |
113 |
0.0007321 |
0.004273 |
797 |
REGULATION OF CLATHRIN MEDIATED ENDOCYTOSIS |
10 |
16 |
0.0007337 |
0.004273 |
798 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
10 |
16 |
0.0007337 |
0.004273 |
799 |
POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
10 |
16 |
0.0007337 |
0.004273 |
800 |
POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
13 |
24 |
0.0008016 |
0.004645 |
801 |
EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS |
13 |
24 |
0.0008016 |
0.004645 |
802 |
POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
13 |
24 |
0.0008016 |
0.004645 |
803 |
CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT |
13 |
24 |
0.0008016 |
0.004645 |
804 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY |
40 |
110 |
0.0008027 |
0.004646 |
805 |
MAINTENANCE OF LOCATION |
48 |
138 |
0.0008125 |
0.004697 |
806 |
NEGATIVE REGULATION OF CYTOPLASMIC TRANSPORT |
42 |
117 |
0.0008158 |
0.00471 |
807 |
G1 DNA DAMAGE CHECKPOINT |
29 |
73 |
0.0008175 |
0.004713 |
808 |
POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT |
46 |
131 |
0.0008197 |
0.00472 |
809 |
NEGATIVE REGULATION OF HOMEOSTATIC PROCESS |
44 |
124 |
0.0008211 |
0.004723 |
810 |
POST GOLGI VESICLE MEDIATED TRANSPORT |
32 |
83 |
0.0008321 |
0.00478 |
811 |
REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS |
85 |
274 |
0.000875 |
0.00502 |
812 |
REGULATION OF MEMBRANE PERMEABILITY |
28 |
70 |
0.0008787 |
0.005029 |
813 |
REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY |
28 |
70 |
0.0008787 |
0.005029 |
814 |
RESPONSE TO DRUG |
126 |
431 |
0.0008871 |
0.005071 |
815 |
SYNAPTIC VESICLE CYCLE |
34 |
90 |
0.0008901 |
0.005075 |
816 |
ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE |
34 |
90 |
0.0008901 |
0.005075 |
817 |
NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS |
47 |
135 |
0.0008946 |
0.005095 |
818 |
HIPPO SIGNALING |
14 |
27 |
0.0008996 |
0.005117 |
819 |
REGULATION OF LIPID BIOSYNTHETIC PROCESS |
45 |
128 |
0.0009019 |
0.005118 |
820 |
MUSCLE CELL DEVELOPMENT |
45 |
128 |
0.0009019 |
0.005118 |
821 |
SECOND MESSENGER MEDIATED SIGNALING |
54 |
160 |
0.0009042 |
0.005124 |
822 |
SKIN DEVELOPMENT |
68 |
211 |
0.0009097 |
0.005149 |
823 |
POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT |
36 |
97 |
0.0009338 |
0.005279 |
824 |
HOMOTYPIC CELL CELL ADHESION |
22 |
51 |
0.0009374 |
0.005293 |
825 |
NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION |
50 |
146 |
0.0009529 |
0.005374 |
826 |
MEMBRANE BIOGENESIS |
15 |
30 |
0.0009688 |
0.005428 |
827 |
SMOOTH MUSCLE CELL DIFFERENTIATION |
15 |
30 |
0.0009688 |
0.005428 |
828 |
NEGATIVE REGULATION OF CELL MATRIX ADHESION |
15 |
30 |
0.0009688 |
0.005428 |
829 |
MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL |
15 |
30 |
0.0009688 |
0.005428 |
830 |
REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS |
33 |
87 |
0.0009694 |
0.005428 |
831 |
REGULATION OF DENDRITIC SPINE MORPHOGENESIS |
15 |
30 |
0.0009688 |
0.005428 |
832 |
REGULATION OF CELL SHAPE |
48 |
139 |
0.0009715 |
0.005433 |
833 |
REGULATION OF SODIUM ION TRANSPORT |
30 |
77 |
0.0009767 |
0.005455 |
834 |
POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION |
11 |
19 |
0.0009782 |
0.005458 |
835 |
LUNG MORPHOGENESIS |
20 |
45 |
0.001005 |
0.005585 |
836 |
POSITIVE REGULATION OF RECEPTOR ACTIVITY |
20 |
45 |
0.001005 |
0.005585 |
837 |
ENDOCHONDRAL BONE MORPHOGENESIS |
20 |
45 |
0.001005 |
0.005585 |
838 |
NEURON RECOGNITION |
16 |
33 |
0.001012 |
0.005607 |
839 |
NUCLEOTIDE SUGAR METABOLIC PROCESS |
16 |
33 |
0.001012 |
0.005607 |
840 |
EMBRYONIC EYE MORPHOGENESIS |
16 |
33 |
0.001012 |
0.005607 |
841 |
RESPONSE TO RADIATION |
121 |
413 |
0.001015 |
0.005618 |
842 |
SULFUR COMPOUND METABOLIC PROCESS |
107 |
359 |
0.001019 |
0.005629 |
843 |
CELL MIGRATION INVOLVED IN HEART DEVELOPMENT |
9 |
14 |
0.00103 |
0.005633 |
844 |
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY |
9 |
14 |
0.00103 |
0.005633 |
845 |
CYTOKINETIC PROCESS |
9 |
14 |
0.00103 |
0.005633 |
846 |
POSITIVE REGULATION OF DNA BINDING |
19 |
42 |
0.001027 |
0.005633 |
847 |
ERBB2 SIGNALING PATHWAY |
18 |
39 |
0.001037 |
0.005633 |
848 |
ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE |
82 |
264 |
0.001024 |
0.005633 |
849 |
METANEPHRIC MESENCHYME DEVELOPMENT |
9 |
14 |
0.00103 |
0.005633 |
850 |
OLFACTORY LOBE DEVELOPMENT |
17 |
36 |
0.001034 |
0.005633 |
851 |
COCHLEA DEVELOPMENT |
18 |
39 |
0.001037 |
0.005633 |
852 |
POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY |
17 |
36 |
0.001034 |
0.005633 |
853 |
CELLULAR RESPONSE TO VITAMIN D |
9 |
14 |
0.00103 |
0.005633 |
854 |
CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS |
9 |
14 |
0.00103 |
0.005633 |
855 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
18 |
39 |
0.001037 |
0.005633 |
856 |
NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION |
18 |
39 |
0.001037 |
0.005633 |
857 |
GLANDULAR EPITHELIAL CELL DIFFERENTIATION |
18 |
39 |
0.001037 |
0.005633 |
858 |
CELL DIVISION |
133 |
460 |
0.001046 |
0.00567 |
859 |
NITROGEN COMPOUND TRANSPORT |
145 |
507 |
0.001047 |
0.00567 |
860 |
RETROGRADE TRANSPORT ENDOSOME TO GOLGI |
29 |
74 |
0.001056 |
0.005714 |
861 |
REGULATION OF MITOTIC CELL CYCLE |
135 |
468 |
0.001064 |
0.005749 |
862 |
MUCOPOLYSACCHARIDE METABOLIC PROCESS |
39 |
108 |
0.00108 |
0.005828 |
863 |
CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN |
43 |
122 |
0.001092 |
0.005887 |
864 |
MITOTIC CELL CYCLE |
210 |
766 |
0.001093 |
0.005888 |
865 |
RESPONSE TO INSULIN |
66 |
205 |
0.001103 |
0.005935 |
866 |
ORGANIC ACID TRANSPORT |
81 |
261 |
0.001124 |
0.00604 |
867 |
O GLYCAN PROCESSING |
24 |
58 |
0.001145 |
0.006139 |
868 |
RESPONSE TO LIGHT STIMULUS |
86 |
280 |
0.001145 |
0.006139 |
869 |
ACTIVIN RECEPTOR SIGNALING PATHWAY |
12 |
22 |
0.001176 |
0.006292 |
870 |
PROTEIN LOCALIZATION TO CELL SURFACE |
12 |
22 |
0.001176 |
0.006292 |
871 |
EAR MORPHOGENESIS |
40 |
112 |
0.001199 |
0.006405 |
872 |
POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
42 |
119 |
0.001202 |
0.006411 |
873 |
REGULATION OF KIDNEY DEVELOPMENT |
23 |
55 |
0.001213 |
0.006466 |
874 |
OVULATION CYCLE PROCESS |
33 |
88 |
0.001217 |
0.006481 |
875 |
RESPONSE TO NUTRIENT |
62 |
191 |
0.001221 |
0.006492 |
876 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
27 |
68 |
0.001229 |
0.006528 |
877 |
HORMONE TRANSPORT |
30 |
78 |
0.001247 |
0.006607 |
878 |
REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS |
30 |
78 |
0.001247 |
0.006607 |
879 |
NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
54 |
162 |
0.001249 |
0.006611 |
880 |
ORGANELLE MEMBRANE FUSION |
35 |
95 |
0.001268 |
0.006703 |
881 |
POSITIVE REGULATION OF REPRODUCTIVE PROCESS |
22 |
52 |
0.00128 |
0.006753 |
882 |
CELLULAR RESPONSE TO IONIZING RADIATION |
22 |
52 |
0.00128 |
0.006753 |
883 |
NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION |
70 |
221 |
0.001299 |
0.006845 |
884 |
REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION |
39 |
109 |
0.001318 |
0.006937 |
885 |
MEMBRANE ASSEMBLY |
13 |
25 |
0.001325 |
0.00694 |
886 |
CELLULAR RESPONSE TO TOXIC SUBSTANCE |
13 |
25 |
0.001325 |
0.00694 |
887 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION |
13 |
25 |
0.001325 |
0.00694 |
888 |
PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
13 |
25 |
0.001325 |
0.00694 |
889 |
POSITIVE REGULATION OF CELL CYCLE ARREST |
32 |
85 |
0.001329 |
0.006954 |
890 |
ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN |
58 |
177 |
0.001342 |
0.007013 |
891 |
POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS |
29 |
75 |
0.001353 |
0.00705 |
892 |
SENSORY PERCEPTION OF PAIN |
29 |
75 |
0.001353 |
0.00705 |
893 |
REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL |
29 |
75 |
0.001353 |
0.00705 |
894 |
GLUCOSE HOMEOSTASIS |
56 |
170 |
0.001402 |
0.007288 |
895 |
CARBOHYDRATE HOMEOSTASIS |
56 |
170 |
0.001402 |
0.007288 |
896 |
REGULATION OF GLOMERULAR FILTRATION |
8 |
12 |
0.001425 |
0.007346 |
897 |
HEMIDESMOSOME ASSEMBLY |
8 |
12 |
0.001425 |
0.007346 |
898 |
LONG TERM MEMORY |
14 |
28 |
0.001426 |
0.007346 |
899 |
MAMMARY GLAND EPITHELIAL CELL PROLIFERATION |
8 |
12 |
0.001425 |
0.007346 |
900 |
EMBRYONIC CAMERA TYPE EYE FORMATION |
8 |
12 |
0.001425 |
0.007346 |
901 |
RESPONSE TO MANGANESE ION |
10 |
17 |
0.00142 |
0.007346 |
902 |
POSITIVE REGULATION OF PHOSPHATASE ACTIVITY |
14 |
28 |
0.001426 |
0.007346 |
903 |
REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY |
8 |
12 |
0.001425 |
0.007346 |
904 |
CYTOKINE PRODUCTION |
42 |
120 |
0.001448 |
0.007439 |
905 |
TRANSITION METAL ION HOMEOSTASIS |
38 |
106 |
0.001448 |
0.007439 |
906 |
FAT CELL DIFFERENTIATION |
38 |
106 |
0.001448 |
0.007439 |
907 |
CRANIAL NERVE DEVELOPMENT |
19 |
43 |
0.001452 |
0.007447 |
908 |
REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY |
49 |
145 |
0.001473 |
0.007549 |
909 |
SCHWANN CELL DIFFERENTIATION |
15 |
31 |
0.001486 |
0.007598 |
910 |
CELLULAR RESPONSE TO GLUCOSE STARVATION |
15 |
31 |
0.001486 |
0.007598 |
911 |
ENDOCRINE PANCREAS DEVELOPMENT |
18 |
40 |
0.00149 |
0.0076 |
912 |
NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
18 |
40 |
0.00149 |
0.0076 |
913 |
LUNG EPITHELIUM DEVELOPMENT |
16 |
34 |
0.001512 |
0.007649 |
914 |
POSITIVE REGULATION OF CATION CHANNEL ACTIVITY |
17 |
37 |
0.001512 |
0.007649 |
915 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
16 |
34 |
0.001512 |
0.007649 |
916 |
RESPONSE TO FLUID SHEAR STRESS |
16 |
34 |
0.001512 |
0.007649 |
917 |
RESPONSE TO NERVE GROWTH FACTOR |
17 |
37 |
0.001512 |
0.007649 |
918 |
RENAL WATER HOMEOSTASIS |
16 |
34 |
0.001512 |
0.007649 |
919 |
GLIAL CELL MIGRATION |
17 |
37 |
0.001512 |
0.007649 |
920 |
AXON EXTENSION |
17 |
37 |
0.001512 |
0.007649 |
921 |
SEGMENTATION |
33 |
89 |
0.001519 |
0.007658 |
922 |
VASCULOGENESIS |
24 |
59 |
0.001519 |
0.007658 |
923 |
REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY |
33 |
89 |
0.001519 |
0.007658 |
924 |
RESPONSE TO TOXIC SUBSTANCE |
75 |
241 |
0.00154 |
0.007755 |
925 |
SPECIFICATION OF SYMMETRY |
41 |
117 |
0.001595 |
0.008025 |
926 |
RESPONSE TO KETONE |
59 |
182 |
0.001634 |
0.008203 |
927 |
PROTEOLYSIS |
317 |
1208 |
0.001634 |
0.008203 |
928 |
NEGATIVE REGULATION OF ORGANELLE ORGANIZATION |
113 |
387 |
0.001654 |
0.008294 |
929 |
REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS |
32 |
86 |
0.001661 |
0.008322 |
930 |
TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER |
51 |
153 |
0.001675 |
0.008382 |
931 |
POSITIVE REGULATION OF TRANSPORTER ACTIVITY |
29 |
76 |
0.001719 |
0.008593 |
932 |
NEURON PROJECTION EXTENSION |
22 |
53 |
0.001725 |
0.00861 |
933 |
RELAXATION OF MUSCLE |
11 |
20 |
0.001729 |
0.008615 |
934 |
ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS |
11 |
20 |
0.001729 |
0.008615 |
935 |
NOTCH SIGNALING PATHWAY |
40 |
114 |
0.001757 |
0.008744 |
936 |
VESICLE ORGANIZATION |
85 |
280 |
0.001778 |
0.00883 |
937 |
PROTEIN TARGETING TO MEMBRANE |
52 |
157 |
0.001777 |
0.00883 |
938 |
REGULATION OF ERBB SIGNALING PATHWAY |
31 |
83 |
0.001817 |
0.009011 |
939 |
NEURAL RETINA DEVELOPMENT |
21 |
50 |
0.001827 |
0.009032 |
940 |
RESPONSE TO GAMMA RADIATION |
21 |
50 |
0.001827 |
0.009032 |
941 |
VISUAL BEHAVIOR |
21 |
50 |
0.001827 |
0.009032 |
942 |
RESPONSE TO OSMOTIC STRESS |
25 |
63 |
0.001852 |
0.009146 |
943 |
NEGATIVE REGULATION OF MOLECULAR FUNCTION |
285 |
1079 |
0.001861 |
0.009183 |
944 |
IN UTERO EMBRYONIC DEVELOPMENT |
93 |
311 |
0.001868 |
0.009206 |
945 |
REGULATION OF MYELOID CELL DIFFERENTIATION |
59 |
183 |
0.001886 |
0.009257 |
946 |
MIDBRAIN DEVELOPMENT |
33 |
90 |
0.001883 |
0.009257 |
947 |
STEROID HORMONE MEDIATED SIGNALING PATHWAY |
43 |
125 |
0.001885 |
0.009257 |
948 |
REGULATION OF GLIOGENESIS |
33 |
90 |
0.001883 |
0.009257 |
949 |
REGULATION OF CALCIUM ION TRANSPORT |
66 |
209 |
0.001904 |
0.009337 |
950 |
ORGANONITROGEN COMPOUND METABOLIC PROCESS |
458 |
1796 |
0.001908 |
0.009343 |
951 |
CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES |
37 |
104 |
0.001938 |
0.009484 |
952 |
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
79 |
258 |
0.001944 |
0.0095 |
953 |
PROTEIN TARGETING TO PLASMA MEMBRANE |
12 |
23 |
0.001954 |
0.009522 |
954 |
REGULATION OF METANEPHROS DEVELOPMENT |
12 |
23 |
0.001954 |
0.009522 |
955 |
REGULATION OF RESPIRATORY GASEOUS EXCHANGE |
12 |
23 |
0.001954 |
0.009522 |
956 |
MULTI MULTICELLULAR ORGANISM PROCESS |
67 |
213 |
0.001973 |
0.009605 |
957 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
24 |
60 |
0.001994 |
0.009693 |
958 |
POSITIVE REGULATION OF CELL CYCLE PROCESS |
76 |
247 |
0.002025 |
0.009834 |
959 |
NEURAL PRECURSOR CELL PROLIFERATION |
27 |
70 |
0.002033 |
0.009864 |
960 |
REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT |
9 |
15 |
0.002056 |
0.009957 |
961 |
CELL COMMUNICATION BY ELECTRICAL COUPLING |
9 |
15 |
0.002056 |
0.009957 |